Modulation	O
of	O
CD28	B-protein
expression	O
:	O
distinct	O
regulatory	O
pathways	O
during	O
activation	O
and	O
replicative	O
senescence	O
.	O

The	O
costimulatory	B-protein
molecule	I-protein
CD28	B-protein
has	O
a	O
restricted	O
tissue	O
distribution	O
and	O
is	O
expressed	O
on	O
T	B-cell_type
cells	I-cell_type
and	O
some	O
plasmacytoma	B-cell_type
cells	I-cell_type
.	O

Although	O
CD28	B-protein
is	O
constitutively	O
expressed	O
,	O
its	O
expression	O
is	O
transiently	O
down-regulated	O
following	O
T	O
cell	O
activation	O
and	O
declines	O
progressively	O
with	O
in	O
vitro	O
senescence	O
.	O

In	O
vivo	O
,	O
CD8+	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
,	O
less	O
frequently	O
,	O
CD4+	B-cell_type
T	I-cell_type
cells	I-cell_type
may	O
completely	O
lose	O
CD28	B-protein
surface	O
expression	O
during	O
chronic	O
infections	O
and	O
with	O
aging	O
.	O

This	O
correlates	O
with	O
changes	O
of	O
nuclear	O
protein-binding	O
activities	O
to	O
two	O
motifs	O
,	O
site	B-protein
alpha	I-protein
and	I-protein
beta	I-protein
,	O
within	O
the	O
CD28	B-DNA
minimal	I-DNA
promoter	I-DNA
.	O

Both	O
alpha-	O
and	O
beta-bound	O
complexes	O
are	O
found	O
only	O
in	O
lymphoid	O
tissues	O
,	O
in	O
CD28+	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
and	O
in	O
some	O
transformed	B-cell_line
B	I-cell_line
cells	I-cell_line
.	O

These	O
complexes	O
are	O
coordinately	O
expressed	O
except	O
during	O
replicative	O
senescence	O
,	O
which	O
is	O
characterized	O
by	O
the	O
down-modulation	O
of	O
site	B-protein
beta	I-protein
-but	O
not	O
site	B-protein
alpha	I-protein
-binding	O
activities	O
.	O

In	O
contrast	O
,	O
T	O
cell	O
activation	O
induces	O
a	O
parallel	O
decline	O
in	O
both	O
site	O
alpha-	O
and	O
beta-binding	O
activities	O
.	O

CD4+	O
and	O
CD8+	B-cell_type
T	I-cell_type
cells	I-cell_type
differ	O
in	O
their	O
beta-binding	O
profiles	O
,	O
which	O
may	O
explain	O
the	O
more	O
pronounced	O
down-regulation	O
of	O
CD28	B-protein
in	O
senescent	O
CD8+	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

In	O
vivo	O
expanded	O
CD4+CD28null	B-cell_line
and	I-cell_line
CD8+CD28null	I-cell_line
T	I-cell_line
cells	I-cell_line
uniformly	O
lack	O
alpha-	B-protein
and	I-protein
beta-	I-protein
bound	I-protein
complexes	I-protein
,	O
resembling	O
the	O
pattern	O
seen	O
in	O
chronically	B-cell_type
activated	I-cell_type
cells	I-cell_type
and	O
not	O
of	O
senescent	B-cell_type
cells	I-cell_type
.	O

a	NULL
Flexible	NULL
,	NULL
Intuitive	NULL
,	NULL
and	NULL
Luminex	NULL
.	NULL

C4	NULL
-	NULL
«	NULL
gf\	NULL
_	NULL
}	NULL
Affordable	NULL
Cytometry	NULL
,	NULL
warmmore	NULL
complexity	NULL
simplified	NULL
.	NULL

Guava®	NULL
easyCyte	NULL
``	NULL
Flow	NULL
Cytometers	NULL
.	NULL

Ln	NULL
mJournal	NULL
f	NULL
Modulation	NULL
of	NULL
CD28	NULL
Expression	NULL
:	NULL
Distinct	NULL
4D	NULL
Immunolo	NULL
gy	NULL
Regulatory	NULL
Pathways	NULL
During	NULL
Activation	NULL
and	NULL
Replicative	NULL
Senescence	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
__	NULL
Abbe	NULL
N.	NULL
Vallejo	NULL
,	NULL
Johann	NULL
C.	NULL
Brandes	NULL
,	NULL
Cornelia	NULL
M.	NULL
Weyand	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019.	NULL
and	NULL
Jorg	NULL
J.	NULL
Goronzy	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:6572-6579	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/11/6572	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
58	NULL
articles	NULL
,	NULL
26	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/11/6572.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Modulation	NULL
of	NULL
CD28	NULL
Expression	NULL
:	NULL
Distinct	NULL
Regulatory	NULL
Pathways	NULL
During	NULL
Activation	NULL
and	NULL
Replicative	NULL
Senescence	NULL
'	NULL
Abbe	NULL
N.	NULL
Vallejo	NULL
,	NULL
``	NULL
Johann	NULL
C.	NULL
Brandes	NULL
,	NULL
``	NULL
Cornelia	NULL
M.	NULL
Weyand	NULL
,	NULL
and	NULL
Jorg	NULL
J.	NULL
Goronzy	NULL
``	NULL
The	NULL
costimulatory	NULL
molecule	NULL
CD28	NULL
has	NULL
a	NULL
restricted	NULL
tissue	NULL
distribution	NULL
and	NULL
is	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
and	NULL
some	NULL
plasmacytoma	NULL
cells	NULL
.	NULL

Although	NULL
CD28	NULL
is	NULL
constitutively	NULL
expressed	NULL
,	NULL
its	NULL
expression	NULL
is	NULL
transiently	NULL
down-regulated	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
declines	NULL
progressively	NULL
with	NULL
in	NULL
vitro	NULL
senescence	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
less	NULL
frequently	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
may	NULL
completely	NULL
lose	NULL
CD28	NULL
surface	NULL
expression	NULL
during	NULL
chronic	NULL
infections	NULL
and	NULL
with	NULL
aging	NULL
.	NULL

This	NULL
correlates	NULL
with	NULL
changes	NULL
of	NULL
nuclear	NULL
protein-binding	NULL
activities	NULL
to	NULL
two	NULL
motifs	NULL
,	NULL
site	NULL
&	NULL
and	NULL
$	NULL
,	NULL
within	NULL
the	NULL
CD28	NULL
minimal	NULL
promoter	NULL
.	NULL

Both	NULL
a-	NULL
and	NULL
-bound	NULL
complexes	NULL
are	NULL
found	NULL
only	NULL
in	NULL
lymphoid	NULL
tissues	NULL
,	NULL
in	NULL
CD28	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
in	NULL
some	NULL
transformed	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
complexes	NULL
are	NULL
coordinately	NULL
expressed	NULL
except	NULL
during	NULL
replicative	NULL
senescence	NULL
,	NULL
which	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
down-modulation	NULL
of	NULL
site	NULL
B-	NULL
but	NULL
not	NULL
site	NULL
«	NULL
-binding	NULL
activities	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
cell	NULL
activation	NULL
induces	NULL
a	NULL
parallel	NULL
decline	NULL
in	NULL
both	NULL
site	NULL
&	NULL
-	NULL
and	NULL
-binding	NULL
activities	NULL
.	NULL

CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
cells	NULL
differ	NULL
in	NULL
their	NULL
-binding	NULL
profiles	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
the	NULL
more	NULL
pronounced	NULL
down-regulation	NULL
of	NULL
CD28	NULL
in	NULL
senescent	NULL
CD8*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
vivo	NULL
expanded	NULL
CD4*CD28	NULL
``	NULL
``	NULL
``	NULL
and	NULL
CD8*	NULL
CD28	NULL
``	NULL
T	NULL
cells	NULL
uniformly	NULL
lack	NULL
a-	NULL
and	NULL
-bound	NULL
complexes	NULL
,	NULL
resembling	NULL
the	NULL
pattern	NULL
seen	NULL
in	NULL
chronically	NULL
activated	NULL
cells	NULL
and	NULL
not	NULL
of	NULL
senescent	NULL
cells	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
6572-6579.	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
T	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Upon	NULL
interaction	NULL
with	NULL
its	NULL
ligands	NULL
CD80	NULL
and	NULL
CD86	NULL
,	NULL
CD28	NULL
transduces	NULL
activation	NULL
signals	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
anti-apoptotic	NULL
proteins	NULL
and	NULL
enhance	NULL
the	NULL
synthesis	NULL
of	NULL
several	NULL
cyto-kines	NULL
including	NULL
IL-2	NULL
.	NULL

Hence	NULL
,	NULL
T	NULL
cells	NULL
should	NULL
either	NULL
become	NULL
anergic	NULL
or	NULL
undergo	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD28-mediated	NULL
signals	NULL
(	NULL
3-6	NULL
)	NULL
.	NULL

Mice	NULL
with	NULL
targeted	NULL
deletion	NULL
of	NULL
the	NULL
CD28	NULL
gene	NULL
are	NULL
severely	NULL
immunocompromised	NULL
.	NULL

These	NULL
gene-knockout	NULL
animals	NULL
are	NULL
unable	NULL
to	NULL
form	NULL
germinal	NULL
centers	NULL
in	NULL
response	NULL
to	NULL
immunization	NULL
,	NULL
and	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
can	NULL
initiate	NULL
,	NULL
but	NULL
not	NULL
sustain	NULL
,	NULL
proliferation	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
attest	NULL
to	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
CD28	NULL
in	NULL
T	NULL
cell-mediated	NULL
immunity	NULL
.	NULL

CD28	NULL
is	NULL
expressed	NULL
on	NULL
nearly	NULL
all	NULL
human	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
CD4TCD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
do	NULL
emerge	NULL
to	NULL
detectable	NULL
levels	NULL
in	NULL
some	NULL
individuals	NULL
with	NULL
aging	NULL
(	NULL
11	NULL
)	NULL
.	NULL

These	NULL
unusual	NULL
T	NULL
cells	NULL
are	NULL
also	NULL
found	NULL
in	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
RA	NULL
)	NULL
*	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
this	NULL
deficiency	NULL
in	NULL
CD28	NULL
expression	NULL
is	NULL
due	NULL
to	NULL
a	NULL
transcriptional	NULL
block	NULL
.	NULL

CD28	NULL
gene	NULL
expression	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
two	NULL
distinct	NULL
sequence	NULL
motifs	NULL
,	NULL
site	NULL
«	NULL
and	NULL
B	NULL
,	NULL
within	NULL
the	NULL
minimal	NULL
promoter	NULL
of	NULL
the	NULL
CD28	NULL
gene	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
either	NULL
sequence	NULL
motif	NULL
abrogate	NULL
CD28	NULL
gene	NULL
promoter	NULL
activities	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
interaction	NULL
between	NULL
proteins	NULL
binding	NULL
to	NULL
both	NULL
sequences	NULL
is	NULL
required	NULL
for	NULL
CD28	NULL
expression	NULL
.	NULL

T	NULL
he	NULL
CD28	NULL
Ag	NULL
is	NULL
the	NULL
major	NULL
costimulatory	NULL
molecule	NULL
required	NULL
Division	NULL
of	NULL
Rheumatology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Mayo	NULL
Clinic	NULL
and	NULL
Foundation	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
Received	NULL
for	NULL
publication	NULL
October	NULL
13	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
8	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
Supported	NULL
by	NULL
the	NULL
Mayo	NULL
Foundation	NULL
,	NULL
the	NULL
Deutscher	NULL
Akademischer	NULL
Austauschdienst	NULL
(	NULL
Germany	NULL
)	NULL
,	NULL
the	NULL
National	NULL
Lupus	NULL
Foundation	NULL
,	NULL
and	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
RO1-AG15043	NULL
,	NULL
RO3-AR45830	NULL
,	NULL
and	NULL
RO1-AR41974	NULL
)	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Jorg	NULL
J.	NULL
Goronzy	NULL
(	NULL
E-mail	NULL
address	NULL
:	NULL
goronzy.jorg	NULL
@	NULL
mayo.edu	NULL
)	NULL
or	NULL
Dr.	NULL
Abbe	NULL
Vallejo	NULL
(	NULL
E-mail	NULL
address	NULL
:	NULL
vallejo.abbe	NULL
@	NULL
mayo.edu	NULL
)	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
200	NULL
First	NULL
Street	NULL
S.W	NULL
.	NULL

,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
.	NULL

3	NULL
Current	NULL
address	NULL
:	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Universitit	NULL
Miinchen	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
.	NULL

*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
RA	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
CD4	NULL
T	NULL
cells	NULL
lack	NULL
DNA-binding	NULL
activities	NULL
for	NULL
both	NULL
sequence	NULL
motifs	NULL
.	NULL

Although	NULL
CD28	NULL
is	NULL
constitutively	NULL
expressed	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
its	NULL
level	NULL
of	NULL
surface	NULL
expression	NULL
is	NULL
not	NULL
static	NULL
.	NULL

At	NULL
least	NULL
two	NULL
mechanisms	NULL
influencing	NULL
CD28	NULL
expression	NULL
have	NULL
been	NULL
reported	NULL
,	NULL
TCR-mediated	NULL
activation	NULL
(	NULL
1	NULL
,	NULL
13	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
replicative	NULL
senescence	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Modulation	NULL
of	NULL
CD28	NULL
cell	NULL
surface	NULL
expression	NULL
is	NULL
of	NULL
particular	NULL
importance	NULL
because	NULL
the	NULL
biological	NULL
outcome	NULL
of	NULL
T	NULL
cell	NULL
stimulation	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
interplay	NULL
of	NULL
four	NULL
molecules	NULL
with	NULL
very	NULL
different	NULL
functions	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
CD28	NULL
and	NULL
CD152	NULL
with	NULL
their	NULL
ligands	NULL
,	NULL
CD80	NULL
and	NULL
CD86	NULL
(	NULL
1	NULL
)	NULL
.	NULL

CD28	NULL
and	NULL
CD152	NULL
are	NULL
related	NULL
glycoproteins	NULL
but	NULL
differ	NULL
greatly	NULL
in	NULL
their	NULL
binding	NULL
properties	NULL
to	NULL
CD80	NULL
and	NULL
CD86	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

They	NULL
both	NULL
have	NULL
fast	NULL
on/off	NULL
rates	NULL
for	NULL
CD80/CD86	NULL
;	NULL
however	NULL
,	NULL
CD152	NULL
has	NULL
a	NULL
10-fold	NULL
higher	NULL
affinity	NULL
for	NULL
these	NULL
molecules	NULL
than	NULL
does	NULL
CD28	NULL
.	NULL

Additionally	NULL
,	NULL
homodimerization	NULL
of	NULL
CD152	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
increase	NULL
its	NULL
avidity	NULL
for	NULL
CD80	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

Differences	NULL
in	NULL
the	NULL
patterns	NULL
of	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
and	NULL
CD152	NULL
will	NULL
,	NULL
therefore	NULL
,	NULL
have	NULL
immediate	NULL
impact	NULL
on	NULL
whether	NULL
a	NULL
positive	NULL
CD28-mediated	NULL
signal	NULL
or	NULL
a	NULL
negative	NULL
CD152-mediated	NULL
signal	NULL
prevails	NULL
.	NULL

We	NULL
have	NULL
now	NULL
explored	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
CD28-associated	NULL
a-	NULL
and	NULL
-specific	NULL
complexes	NULL
in	NULL
fine-tuning	NULL
the	NULL
level	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

Surprisingly	NULL
,	NULL
these	NULL
two	NULL
nuclear	NULL
protein	NULL
complexes	NULL
were	NULL
detected	NULL
exclusively	NULL
in	NULL
lymphoid	NULL
cells	NULL
and	NULL
,	NULL
in	NULL
most	NULL
instances	NULL
,	NULL
their	NULL
binding	NULL
activities	NULL
were	NULL
coordinated	NULL
.	NULL

Upon	NULL
TCR	NULL
ligation	NULL
,	NULL
transient	NULL
diminution	NULL
of	NULL
both	NULL
DNA-binding	NULL
activities	NULL
was	NULL
observed	NULL
accompanied	NULL
by	NULL
the	NULL
down-regulation	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
was	NULL
a	NULL
progressive	NULL
loss	NULL
of	NULL
CD28	NULL
expression	NULL
during	NULL
replicative	NULL
senescence	NULL
that	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
site	NULL
B-	NULL
,	NULL
but	NULL
not	NULL
in	NULL
site	NULL
&	NULL
-	NULL
,	NULL
binding	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
CD28	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
protein	NULL
complexes	NULL
binding	NULL
to	NULL
sites	NULL
«	NULL
and	NULL
B	NULL
.	NULL

However	NULL
,	NULL
distinct	NULL
mechanisms	NULL
lead	NULL
to	NULL
CD28	NULL
down-regulation	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
during	NULL
replicative	NULL
senescence	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
established	NULL
by	NULL
limiting	NULL
dilution	NULL
cloning	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
clones	NULL
were	NULL
derived	NULL
from	NULL
PBMC	NULL
of	NULL
healthy	NULL
do	NULL
nors	NULL
or	NULL
RA	NULL
patients	NULL
,	NULL
some	NULL
of	NULL
whom	NULL
have	NULL
participated	NULL
in	NULL
previous	NULL
studies	NULL
(	NULL
11	NULL
,	NULL
22-24	NULL
)	NULL
.	NULL

Culture	NULL
conditions	NULL
for	NULL
these	NULL
clones	NULL
have	NULL
been	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Short	NULL
and	NULL
long	NULL
term	NULL
cultures	NULL
of	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
from	NULL
PBMC	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
stimulation	NULL
with	NULL
1	NULL
ug/ml	NULL
PHA	NULL
(	NULL
Sigma	NULL
Chem-ical	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

After	NULL
10	NULL
days	NULL
,	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
the	NULL
VarioMACS	NULL
system	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
by	NULL
standard	NULL
panning	NULL
protocols	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
these	NULL
lymphocyte	NULL
populations	NULL
was	NULL
confirmed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
cells	NULL
stained	NULL
for	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
.	NULL

Sublines	NULL
of	NULL
CD28*	NULL
and	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
cells	NULL
from	NULL
both	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
by	NULL
standard	NULL
FACS	NULL
procedures	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
by	NULL
a	NULL
weekly	NULL
stimulation	NULL
with	NULL
y-irradiated	NULL
neuraminidase/galactose	NULL
oxidase-treated	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
and	NULL
15	NULL
U/ml	NULL
exogenous	NULL
IL-2	NULL
.	NULL

The	NULL
plasmacytoma	NULL
cell	NULL
lines	NULL
ANBL/6	NULL
,	NULL
KAS6/1	NULL
,	NULL
and	NULL
KP6	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
Diane	NULL
Jelinek	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
)	NULL
were	NULL
originally	NULL
isolated	NULL
from	NULL
patients	NULL
with	NULL
multiple	NULL
myeloma	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

They	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
Summit	NULL
Biotech	NULL
,	NULL
Ft.	NULL
Collins	NULL
,	NULL
CO	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
!	NULL

streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
1	NULL
ng/ml	NULL
human	NULL
recombinant	NULL
IL-6	NULL
(	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
BIN40	NULL
,	NULL
HT1O	NULL
,	NULL
MGAR	NULL
,	NULL
Rei	NULL
,	NULL
and	NULL
TABO85	NULL
)	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
established	NULL
in	NULL
our	NULL
laboratory	NULL
by	NULL
standard	NULL
protocols	NULL
or	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
11th	NULL
Histocompatibility	NULL
Workshop	NULL
.	NULL

The	NULL
PJL	NULL
cell	NULL
line	NULL
(	NULL
27	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Paul	NULL
Leibson	NULL
(	NULL
Mayo	NULL
Clinic	NULL
)	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
same	NULL
culture	NULL
media	NULL
used	NULL
for	NULL
the	NULL
plasmacytomas	NULL
but	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
IL-6	NULL
.	NULL

Various	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

These	NULL
include	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
Ramos	NULL
;	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
Jurkat	NULL
,	NULL
HUT78	NULL
,	NULL
and	NULL
6TCEM20	NULL
;	NULL
the	NULL
epithelial	NULL
carcinoma	NULL
lines	NULL
,	NULL
HeLa	NULL
and	NULL
Colo320HSR	NULL
;	NULL
the	NULL
erythroleukemia	NULL
line	NULL
,	NULL
K562	NULL
;	NULL
the	NULL
promonocytic	NULL
line	NULL
U937	NULL
;	NULL
and	NULL
the	NULL
rhabdomyosarcoma	NULL
line	NULL
,	NULL
RD	NULL
.	NULL

Cells	NULL
were	NULL
propagated	NULL
according	NULL
to	NULL
ATCC	NULL
recommendations	NULL
.	NULL

Flow	NULL
cytometry	NULL
Phenotypes	NULL
of	NULL
cells	NULL
were	NULL
periodically	NULL
examined	NULL
by	NULL
standard	NULL
flow	NULL
cytometry	NULL
procedures	NULL
.	NULL

This	NULL
involved	NULL
triple	NULL
immunofluorescence	NULL
staining	NULL
with	NULL
Abs	NULL
to	NULL
CD3	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
and	NULL
analysis	NULL
by	NULL
FACSVantage	NULL
or	NULL
FACSCali-bur	NULL
cytometers	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Each	NULL
experiment	NULL
included	NULL
cells	NULL
incubated	NULL
with	NULL
isotype	NULL
controls	NULL
(	NULL
Simultest	NULL
,	NULL
Becton	NULL
Dickinson	NULL
}	NULL
.	NULL

Analysis	NULL
of	NULL
cell	NULL
populations	NULL
were	NULL
done	NULL
using	NULL
the	NULL
WinMDI	NULL
program	NULL
(	NULL
J.Trot-ter	NULL
,	NULL
Scripps	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Reverse	NULL
transcriptase-PCR	NULL
The	NULL
presence	NULL
of	NULL
CD28	NULL
mRNA	NULL
in	NULL
the	NULL
various	NULL
cells	NULL
was	NULL
assessed	NULL
by	NULL
standard	NULL
RT-PCR	NULL
.	NULL

Experiments	NULL
were	NULL
conducted	NULL
using	NULL
amplification	NULL
primers	NULL
appropriately	NULL
designed	NULL
to	NULL
detect	NULL
the	NULL
different	NULL
splice	NULL
forms	NULL
of	NULL
CD28	NULL
mRNA	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

To	NULL
amplify	NULL
CD28	NULL
transcripts	NULL
containing	NULL
exons	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
,	NULL
PCR	NULL
was	NULL
done	NULL
with	NULL
the	NULL
primers	NULL
CTCAGGCTGCTCTITTGGCTCTC	NULL
,	NULL
CGCCCAT	NULL
GCTTGTAGCGTACG	NULL
,	NULL
and	NULL
CAAGCCAGGACTCCACCAACC	NULL
,	NULL
respectively	NULL
,	NULL
paired	NULL
with	NULL
the	NULL
common	NULL
primer	NULL
GATAGGCTGCGAAGTCGCGTC	NULL
corresponding	NULL
to	NULL
the	NULL
3'-end	NULL
of	NULL
exon	NULL
4	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
fractionated	NULL
in	NULL
2	NULL
%	NULL
agarose	NULL
gels	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
There	NULL
were	NULL
two	NULL
T	NULL
cell	NULL
activation	NULL
procedures	NULL
.	NULL

In	NULL
one	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
triplicate	NULL
cultures	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
autologous	NULL
,	NULL
freshly	NULL
isolated	NULL
,	NULL
plastic-adherent	NULL
monocytes	NULL
and	NULL
5	NULL
pg/ml	NULL
soluble	NULL
anti-CD3	NULL
Ab	NULL
(	NULL
OKT3	NULL
,	NULL
ATCC	NULL
)	NULL
.	NULL

In	NULL
other	NULL
studies	NULL
,	NULL
T	NULL
cell	NULL
cultures	NULL
were	NULL
incubated	NULL
on	NULL
immobilized	NULL
OKT3	NULL
and	NULL
the	NULL
anti-CD28	NULL
mAb	NULL
28.2	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
OKT3	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
28.2	NULL
(	NULL
300	NULL
ng/m	NULL
!	NULL
)	NULL

mAbs	NULL
were	NULL
immobilized	NULL
on	NULL
rabbit	NULL
anti-mouse	NULL
Ig-coated	NULL
plates	NULL
.	NULL

These	NULL
Ab	NULL
concentrations	NULL
were	NULL
determined	NULL
to	NULL
induce	NULL
proliferation	NULL
of	NULL
freshly	NULL
isolated	NULL
and	NULL
short	NULL
term	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

As	NULL
system	NULL
controls	NULL
,	NULL
T	NULL
cell	NULL
cultures	NULL
that	NULL
were	NULL
stimulated	NULL
with	NULL
50	NULL
ng/ml	NULL
PMA	NULL
and	NULL
10	NULL
nM	NULL
ionomycin	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
IgG	NULL
isotype	NULL
controls	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Surgical	NULL
tissue	NULL
specimens	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Surgical	NULL
Pathology	NULL
Lab-oratories	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
cut	NULL
into	NULL
small	NULL
pieces	NULL
,	NULL
and	NULL
digested	NULL
with	NULL
collagenase	NULL
by	NULL
standard	NULL
techniques	NULL
.	NULL

Single-cell	NULL
suspensions	NULL
were	NULL
obtained	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
between	NULL
5	NULL
X	NULL
10°	NULL
and	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
cold	NULL
HEPES	NULL
hypotonic	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
nuclei	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
.	NULL

Nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
a	NULL
high	NULL
salt	NULL
buffer	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
protein	NULL
assay	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Similar	NULL
nuclear	NULL
extract	NULL
preparations	NULL
were	NULL
made	NULL
with	NULL
cell	NULL
lines	NULL
as	NULL
indicated	NULL
.	NULL

6573	NULL
ct	NULL
-	NULL
400	NULL
-	NULL
300	NULL
-	NULL
200	NULL
-	NULL
100	NULL
{	NULL
1	NULL
l	NULL
I	NULL
|	NULL
|	NULL
-Jate	NULL
&	NULL
<	NULL
$	NULL
3	NULL
'maetcatcaaaacaacertatatccretereamatectecactcaceateccrrereerrreactecetreat	NULL
.	NULL

Site	NULL
y	NULL
site	NULL
;	NULL
FIGURE	NULL
1	NULL
.	NULL

-	NULL
Structure	NULL
of	NULL
the	NULL
CD28	NULL
minimal	NULL
promoter	NULL
.	NULL

The	NULL
proximal	NULL
400	NULL
bp	NULL
flanking	NULL
the	NULL
translation	NULL
initiation	NULL
codon	NULL
has	NULL
been	NULL
found	NULL
to	NULL
comprise	NULL
the	NULL
minimal	NULL
CD28	NULL
promoter	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Two	NULL
sequence	NULL
motifs	NULL
,	NULL
sites	NULL
«	NULL
and	NULL
B	NULL
,	NULL
situated	NULL
downstream	NULL
from	NULL
the	NULL
CAAT	NULL
and	NULL
TATA	NULL
boxes	NULL
have	NULL
been	NULL
identified	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

CD4	NULL
T	NULL
cells	NULL
uniformly	NULL
show	NULL
a	NULL
lack	NULL
of	NULL
specific	NULL
nuclear	NULL
factor	NULL
binding	NULL
activities	NULL
to	NULL
both	NULL
sequences	NULL
.	NULL

Furthermore	NULL
,	NULL
mutations	NULL
in	NULL
either	NULL
motif	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
effectively	NULL
inactivate	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
.	NULL

EMSAs	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
,	NULL
30	NULL
)	NULL
,	NULL
Briefly	NULL
,	NULL
~20	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
were	NULL
combined	NULL
with	NULL
30	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
containing	NULL
3	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
ICN	NULL
Pharmaceuticals	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
nonspecific	NULL
oligonucleotide	NULL
.	NULL

To	NULL
this	NULL
mixture	NULL
,	NULL
5	NULL
pl	NULL
of	NULL
wash	NULL
buffer	NULL
were	NULL
added	NULL
,	NULL
and	NULL
the	NULL
total	NULL
reaction	NULL
volume	NULL
was	NULL
adjusted	NULL
to	NULL
50	NULL
pl	NULL
with	NULL
binding	NULL
buffer	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
.	NULL

About	NULL
40	NULL
fmol	NULL
of	NULL
radio-labeled	NULL
probes	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
oligonucleotide	NULL
probes	NULL
corresponding	NULL
to	NULL
the	NULL
site	NULL
«	NULL
and	NULL
B	NULL
motifs	NULL
were	NULL
synthesized	NULL
as	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
in	NULL
6	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
autoradiography	NULL
.	NULL

Generally	NULL
,	NULL
each	NULL
experiment	NULL
consisted	NULL
of	NULL
replicate	NULL
reactions	NULL
of	NULL
two	NULL
separate	NULL
preparations	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
the	NULL
same	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
reproducibility	NULL
of	NULL
EMSAs	NULL
was	NULL
assessed	NULL
by	NULL
repeated	NULL
experiments	NULL
as	NULL
indicated	NULL
.	NULL

As	NULL
in	NULL
previous	NULL
work	NULL
(	NULL
11	NULL
)	NULL
,	NULL
the	NULL
specificities	NULL
of	NULL
e-/B-binding	NULL
activities	NULL
were	NULL
validated	NULL
by	NULL
three	NULL
criteria	NULL
:	NULL
1	NULL
)	NULL
the	NULL
higher	NULL
mobility	NULL
of	NULL
«	NULL
-bound	NULL
complexes	NULL
compared	NULL
with	NULL
B-bound	NULL
complexes	NULL
;	NULL
2	NULL
)	NULL
the	NULL
lack	NULL
of	NULL
reciprocal	NULL
competition	NULL
between	NULL
the	NULL
two	NULL
motifs	NULL
;	NULL
and	NULL
3	NULL
)	NULL
by	NULL
irrelevant	NULL
probes	NULL
.	NULL

The	NULL
irrelevant	NULL
probes	NULL
(	NULL
Ets-1	NULL
,	NULL
Elk-1	NULL
,	NULL
AP3	NULL
,	NULL
and	NULL
NFB	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
SP1	NULL
sequence	NULL
was	NULL
used	NULL
as	NULL
an	NULL
experimental	NULL
system	NULL
control	NULL
(	NULL
11	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
CD28-specific	NULL
transcription	NULL
factors	NULL
in	NULL
CD28	NULL
``	NULL
and	NULL
CD28	NULL
``	NULL
lymphoid	NULL
cells	NULL
In	NULL
previous	NULL
studies	NULL
(	NULL
11	NULL
)	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
CD28	NULL
expression	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
was	NULL
correlated	NULL
with	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
CD28	NULL
minimal	NULL
promoter	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
sites	NULL
a	NULL
and	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
EMSAs	NULL
,	NULL
probes	NULL
corresponding	NULL
to	NULL
site	NULL
«	NULL
yielded	NULL
a	NULL
single	NULL
band	NULL
,	NULL
while	NULL
a	NULL
faster	NULL
and	NULL
a	NULL
slower	NULL
migrating	NULL
band	NULL
were	NULL
found	NULL
with	NULL
probes	NULL
corresponding	NULL
to	NULL
site	NULL
.	NULL

Introduction	NULL
of	NULL
mutations	NULL
into	NULL
either	NULL
motif	NULL
resulted	NULL
in	NULL
the	NULL
inactivation	NULL
of	NULL
promoter	NULL
ac-tivity	NULL
,	NULL
suggesting	NULL
that	NULL
CD28	NULL
expression	NULL
requires	NULL
the	NULL
coordinated	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
both	NULL
sequence	NULL
motifs	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
correlation	NULL
between	NULL
CD28	NULL
expression	NULL
and	NULL
CD28-specific	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
analyzed	NULL
various	NULL
lymphoid	NULL
cells	NULL
that	NULL
differ	NULL
in	NULL
CD28	NULL
expression	NULL
.	NULL

Representative	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
various	NULL
cell	NULL
lines	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
I.	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
sorted	NULL
for	NULL
their	NULL
expression	NULL
of	NULL
CD28	NULL
,	NULL
and	NULL
CD28*	NULL
and	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
were	NULL
analyzed	NULL
separately	NULL
.	NULL

The	NULL
vast	NULL
majority	NULL
of	NULL
peripheral	NULL
blood	NULL
CD4*	NULL
T	NULL
cells	NULL
expressed	NULL
the	NULL
CD28	NULL
molecule	NULL
.	NULL

A	NULL
subset	NULL
of	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
CD4*	NULL
T	NULL
cells	NULL
existed	NULL
only	NULL
in	NULL
some	NULL
individuals	NULL
,	NULL
in	NULL
whom	NULL
such	NULL
cells	NULL
comprised	NULL
<	NULL
5	NULL
%	NULL
of	NULL
the	NULL
CD4	NULL
T	NULL
cell	NULL
compartment	NULL
(	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
CD8TCD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
were	NULL
common	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
lacked	NULL
CD28	NULL
mRNA	NULL
as	NULL
determined	NULL
by	NULL
RT-PCR	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Cell	NULL
surface	NULL
density	NULL
of	NULL
CD28	NULL
on	NULL
peripheral	NULL
CD28	NULL
and	NULL
CD28	NULL
*CD4*	NULL
T	NULL
cells	NULL
was	NULL
equivalent	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
T	NULL
cells	NULL
,	NULL
plasmacytoma	NULL
cells	NULL
and	NULL
some	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
had	NULL
a	NULL
dim	NULL
expression	NULL
of	NULL
CD28	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
results	NULL
are	NULL
shown	NULL
for	NULL
the	NULL
plasmacytoma	NULL
cell	NULL
lines	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6574	NULL
Primary	NULL
T	NULL
cell	NULL
lines	NULL
co4tcoas+	NULL
A	NULL
costcpas+	NULL
H	NULL
I\	NULL
4	NULL
}	NULL
P	NULL
100	NULL
_	NULL
101	NULL
102	NULL
fos	NULL
-	NULL
40+	NULL
40°	NULL
_	NULL
101	NULL
102	NULL
103	NULL
0	NULL
104	NULL
a	NULL
Plasmacytomas	NULL
T	NULL
ANBL/6	NULL
%	NULL
Kasem	NULL
$	NULL
®	NULL
f	NULL
o	NULL
\	NULL
c.	NULL
.	NULL

5	NULL
|	NULL
3	NULL
g	NULL
101	NULL
10	NULL
-	NULL
100	NULL
101	NULL
102	NULL
3	NULL
h	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
lines	NULL
PJL	NULL
MGAR	NULL
101	NULL
102	NULL
-	NULL
109	NULL
i	NULL
101	NULL
i	NULL
102	NULL
CD28	NULL
expression	NULL
(	NULL
fluorescence	NULL
intensity	NULL
)	NULL
FIGURE	NULL
2	NULL
.	NULL

CD28	NULL
expression	NULL
on	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

Levels	NULL
of	NULL
CD28	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
on	NULL
various	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
were	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
CD28	NULL
expression	NULL
(	NULL
solid	NULL
lines	NULL
)	NULL
were	NULL
generally	NULL
seen	NULL
on	NULL
short	NULL
term	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
plasmacytoma	NULL
lines	NULL
and	NULL
some	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
showed	NULL
significantly	NULL
lower	NULL
but	NULL
detectable	NULL
levels	NULL
of	NULL
anti-CD28	NULL
staining	NULL
when	NULL
compared	NULL
with	NULL
isotype	NULL
controls	NULL
(	NULL
dashed	NULL
lines	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
a	NULL
panel	NULL
of	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
showed	NULL
a	NULL
correlation	NULL
between	NULL
CD28	NULL
cell	NULL
surface	NULL
expression	NULL
and	NULL
specific	NULL
transcripts	NULL
(	NULL
see	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

CD28	NULL
``	NULL
``	NULL
``	NULL
cells	NULL
uniformly	NULL
lack	NULL
CD28	NULL
mRNA	NULL
as	NULL
determined	NULL
by	NULL
RT-PCR	NULL
.	NULL

ANBL/6	NULL
and	NULL
KAS6/1	NULL
.	NULL

Both	NULL
cell	NULL
lines	NULL
had	NULL
low	NULL
levels	NULL
of	NULL
CD28	NULL
expression	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
transcribed	NULL
CD28	NULL
mRNA	NULL
as	NULL
determined	NULL
by	NULL
RT-PCR	NULL
.	NULL

The	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
PJL	NULL
had	NULL
a	NULL
minimal	NULL
cell	NULL
surface	NULL
staining	NULL
for	NULL
CD28	NULL
and	NULL
expressed	NULL
CD28	NULL
mRNA	NULL
,	NULL
whereas	NULL
the	NULL
lymphoblastoid	NULL
B	NULL
cell	NULL
line	NULL
MGAR	NULL
was	NULL
negative	NULL
for	NULL
CD28	NULL
mRNA	NULL
and	NULL
lacked	NULL
cell	NULL
surface	NULL
CD28	NULL
expression	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
all	NULL
of	NULL
the	NULL
cell	NULL
types	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
were	NULL
analyzed	NULL
for	NULL
proteins	NULL
binding	NULL
to	NULL
sites	NULL
«	NULL
and	NULL
3	NULL
of	NULL
the	NULL
CD28	NULL
minimal	NULL
promoter	NULL
.	NULL

Results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
demonstrate	NULL
a	NULL
correlation	NULL
between	NULL
the	NULL
presence	NULL
of	NULL
site	NULL
a-bound	NULL
complexes	NULL
(	NULL
band	NULL
A	NULL
)	NULL
and	NULL
CD28	NULL
expression	NULL
,	NULL
irrespective	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
density	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

Among	NULL
the	NULL
T	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
examined	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
site	NULL
«	NULL
-specific	NULL
proteins	NULL
was	NULL
highly	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
CD28	NULL
mRNA	NULL
.	NULL

The	NULL
results	NULL
were	NULL
more	NULL
complex	NULL
for	NULL
site	NULL
B	NULL
.	NULL

Although	NULL
all	NULL
CD28	NULL
*	NULL
and	NULL
no	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
cells	NULL
showed	NULL
site	NULL
-binding	NULL
activities	NULL
,	NULL
the	NULL
mobility	NULL
patterns	NULL
of	NULL
the	NULL
DNA-protein	NULL
complexes	NULL
varied	NULL
among	NULL
the	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

CD4*CD28	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
CD28	NULL
*	NULL
T	NULL
cell	NULL
tumor	NULL
line	NULL
Jurkat	NULL
showed	NULL
two	NULL
B-bound	NULL
complexes	NULL
,	NULL
a	NULL
slow	NULL
mobility	NULL
B1	NULL
band	NULL
and	NULL
a	NULL
faster	NULL
mobility	NULL
B2	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
CD28	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
CD28	NULL
*	NULL
plasmacytoma	NULL
and	NULL
EBV	NULL
-transformed	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
had	NULL
a	NULL
complete	NULL
loss	NULL
or	NULL
significant	NULL
diminution	NULL
of	NULL
the	NULL
slow	NULL
migrating	NULL
B1	NULL
complex	NULL
.	NULL

The	NULL
diminution	NULL
of	NULL
the	NULL
B1	NULL
complex	NULL
was	NULL
apparently	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
low	NULL
expression	NULL
of	NULL
CD28	NULL
on	NULL
B	NULL
cells	NULL
.	NULL

CD8	NULL
*	NULL
T	NULL
cells	NULL
lacking	NULL
this	NULL
band	NULL
showed	NULL
a	NULL
level	NULL
of	NULL
CD28	NULL
cell	NULL
surface	NULL
expression	NULL
that	NULL
was	NULL
equivalent	NULL
to	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
CD28-specific	NULL
transcription	NULL
factors	NULL
is	NULL
limited	NULL
to	NULL
lymphoid	NULL
tissue	NULL
As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
site	NULL
a-	NULL
and	NULL
B-binding	NULL
proteins	NULL
in	NULL
lymphoid	NULL
cells	NULL
was	NULL
strictly	NULL
correlated	NULL
with	NULL
CD28	NULL
expression	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
DNA-protein	NULL
complexes	NULL
was	NULL
highly	NULL
synchronous	NULL
in	NULL
that	NULL
none	NULL
of	NULL
the	NULL
CD28	NULL
*	NULL
cells	NULL
examined	NULL
REGULATORY	NULL
MOTIFS	NULL
CONTROLLING	NULL
CD28	NULL
EXPRESSION	NULL
Table	NULL
I	NULL
.	NULL

_	NULL
CD28	NULL
expression	NULL
in	NULL
various	NULL
human	NULL
cell	NULL
lines	NULL
Cell	NULL
Line	NULL
Surface	NULL
CD28	NULL
``	NULL
CD28	NULL
mRNA®	NULL
Primary	NULL
CD4*	NULL
T	NULL
cell	NULL
lines	NULL
J28P	NULL
High	NULL
+	NULL
J28N	NULL
Null	NULL
T28P	NULL
High	NULL
+	NULL
T28N	NULL
Null	NULL
Primary	NULL
CD8*	NULL
T	NULL
cell	NULL
lines	NULL
F32-8P	NULL
High	NULL
+	NULL
F32-8N	NULL
Null	NULL
DH-8P	NULL
High	NULL
+	NULL
DH-8N	NULL
Null	NULL
T	NULL
cell	NULL
lymphomas	NULL
Jurkat	NULL
High	NULL
+	NULL
6GTCEM20	NULL
High	NULL
+	NULL
HUT78	NULL
Null	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
BIN40	NULL
Null	NULL
HT10	NULL
Low	NULL
+	NULL
MGAR	NULL
Null	NULL
PJL	NULL
Low	NULL
+	NULL
Rei	NULL
Low	NULL
+	NULL
TABO85	NULL
Low	NULL
+	NULL
B	NULL
cell	NULL
lymphoma	NULL
Ramos	NULL
Low	NULL
+	NULL
Plasmacytomas	NULL
ANBL6	NULL
Low	NULL
+	NULL
KP6	NULL
Low	NULL
+	NULL
KAS61	NULL
Low	NULL
+	NULL
Proerythroid	NULL
leukemia	NULL
cell	NULL
line	NULL
K562	NULL
Null	NULL
Promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
Null	NULL
Rhabdomyosarcoma	NULL
RD	NULL
Null	NULL
Epithelioid	NULL
carcinoma	NULL
cell	NULL
line	NULL
HeLa	NULL
Null	NULL
Colo320HSR	NULL
Null	NULL
``	NULL
Determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

High	NULL
refers	NULL
to	NULL
<	NULL
1	NULL
log	NULL
magnitude	NULL
and	NULL
low	NULL
refers	NULL
to	NULL
>	NULL
%	NULL
4	NULL
and	NULL
<	NULL
1	NULL
log	NULL
magnitude	NULL
of	NULL
CD28	NULL
expression	NULL
over	NULL
an	NULL
isotype	NULL
control	NULL
.	NULL

Null	NULL
refers	NULL
to	NULL
CD28	NULL
expression	NULL
equivalent	NULL
to	NULL
an	NULL
isotype	NULL
control	NULL
.	NULL

*	NULL
Determined	NULL
by	NULL
RT-PCR	NULL
.	NULL

expressed	NULL
only	NULL
one	NULL
of	NULL
these	NULL
two	NULL
complexes	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
data	NULL
(	NULL
11	NULL
)	NULL
,	NULL
reciprocal	NULL
competition	NULL
assays	NULL
showed	NULL
that	NULL
site	NULL
«	NULL
and	NULL
BB	NULL
probes	NULL
do	NULL
not	NULL
block	NULL
motif-specific	NULL
binding	NULL
activities	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
«	NULL
-	NULL
and	NULL
B-bound	NULL
complexes	NULL
are	NULL
truly	NULL
lym-phoid-specific	NULL
and	NULL
are	NULL
synchronously	NULL
expressed	NULL
,	NULL
we	NULL
examined	NULL
a	NULL
series	NULL
of	NULL
tissues	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
site	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
were	NULL
found	NULL
only	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
were	NULL
uniformly	NULL
absent	NULL
in	NULL
all	NULL
other	NULL
tissues	NULL
examined	NULL
.	NULL

Reciprocal	NULL
competitive	NULL
EMSAs	NULL
between	NULL
the	NULL
two	NULL
sequences	NULL
revealed	NULL
that	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
splenic	NULL
extracts	NULL
were	NULL
site	NULL
a-	NULL
and	NULL
-specific	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
surgical	NULL
tissue	NULL
specimens	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
proerythroid	NULL
leukemia	NULL
cell	NULL
line	NULL
K562	NULL
,	NULL
the	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
,	NULL
the	NULL
rhabdomyosarcoma	NULL
cell	NULL
line	NULL
RD	NULL
,	NULL
and	NULL
the	NULL
epithelioid	NULL
carcinoma	NULL
cell	NULL
lines	NULL
HeLa	NULL
and	NULL
Colo320HSR	NULL
were	NULL
analyzed	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
expressed	NULL
CD28	NULL
at	NULL
neither	NULL
the	NULL
protein	NULL
nor	NULL
the	NULL
mRNA	NULL
levels	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
EMSAs	NULL
,	NULL
these	NULL
cells	NULL
also	NULL
lacked	NULL
binding	NULL
activities	NULL
to	NULL
site	NULL
a	NULL
and	NULL
B	NULL
sequences	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Modulation	NULL
of	NULL
CD28	NULL
expression	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
Although	NULL
CD28	NULL
is	NULL
constitutively	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
activating	NULL
stimuli	NULL
induce	NULL
a	NULL
transient	NULL
reduction	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
CD28	NULL
expression	NULL
(	NULL
1	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
T	NULL
cells	NULL
cocultured	NULL
with	NULL
autologous	NULL
monocytes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
elicited	NULL
the	NULL
down-regulation	NULL
of	NULL
CD28	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
after	NULL
24	NULL
h	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6575	NULL
site	NULL
o.	NULL
site	NULL
B	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Site	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
B	NULL
cells	NULL
B	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
were	NULL
plasma-	NULL
plasma-*	NULL
T	NULL
cells	NULL
EBV	NULL
T	NULL
cells	NULL
EBV	NULL
prepared	NULL
and	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
oligonucleotide	NULL
cytoma	NULL
cytoma	NULL
prlobes	NULL
correspond-mg	NULL
to	NULL
$	NULL
1th	NULL
a	NULL
and	NULL
B	NULL
as	NULL
inldi0f1tled	NULL
in	NULL
z	NULL
i	NULL
g	NULL
E	NULL
8	NULL
g	NULL
é	NULL
to	NULL
s	NULL
3	NULL
,	NULL
i	NULL
i	NULL
g	NULL
E	NULL
€	NULL
g	NULL
é	NULL
to	NULL
C	NULL
g	NULL
_	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

As	NULL
in	NULL
previous	NULL
studies	NULL
(	NULL
11	NULL
)	NULL
,	NULL
the	NULL
specificities	NULL
of	NULL
o	NULL
o	NULL
o	NULL
o	NULL
5	NULL
z	NULL
$	NULL
&	NULL
O	NULL
&	NULL
5	NULL
o	NULL
o	NULL
o	NULL
o	NULL
5	NULL
Z	NULL
$	NULL
%	NULL
O	NULL
5	NULL
S	NULL
he	NULL
&	NULL
ras	NULL
0	NULL
0	NULL
0	NULL
O	NULL
5	NULL
<	NULL
x	NULL
23	NULL
m	NULL
o	NULL
0	NULL
0	NULL
0	NULL
O	NULL
5	NULL
<	NULL
x	NULL
2	NULL
m	NULL
o	NULL
DNA-protein	NULL
interactions	NULL
were	NULL
indicated	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
_	NULL
£	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
-	NULL
-	NULL
+	NULL
Bot	NULL
=o	NULL
$	NULL
$	NULL
o	NULL
$	NULL
o	NULL
4	NULL
&	NULL
0	NULL
-o-	NULL
+	NULL
reciprocal	NULL
competition	NULL
between	NULL
a	NULL
and	NULL
B	NULL
probes	NULL
and	NULL
the	NULL
inability	NULL
of	NULL
other	NULL
probes	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
consensus	NULL
Ets-1	NULL
,	NULL
Elk-1	NULL
,	NULL
AP3	NULL
,	NULL
and	NULL
NFB	NULL
)	NULL
to	NULL
outcompete	NULL
a-	NULL
and	NULL
B-bound	NULL
complexes	NULL
.	NULL

The	NULL
SP1-binding	NULL
profiles	NULL
were	NULL
similar	NULL
among	NULL
the	NULL
various	NULL
cells	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Autoradiograms	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

culture	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

We	NULL
then	NULL
examined	NULL
whether	NULL
this	NULL
phenomenon	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
specific	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
a	NULL
and	NULL
B	NULL
of	NULL
the	NULL
CD28	NULL
gene	NULL
promoter	NULL
.	NULL

As	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
T	NULL
cell	NULL
stimulation	NULL
resulted	NULL
in	NULL
a	NULL
parallel	NULL
reduction	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
specific	NULL
binding	NULL
activities	NULL
to	NULL
both	NULL
motifs	NULL
within	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
.	NULL

These	NULL
reductions	NULL
in	NULL
site	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
were	NULL
seen	NULL
in	NULL
both	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
activation-induced	NULL
changes	NULL
in	NULL
both	NULL
the	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
and	NULL
the	NULL
-/	NULL
-binding	NULL
activities	NULL
were	NULL
transient	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
«	NULL
-/B-binding	NULL
activities	NULL
returned	NULL
to	NULL
baseline	NULL
levels	NULL
after	NULL
72	NULL
h	NULL
,	NULL
whereas	NULL
the	NULL
cell	NULL
surface	NULL
levels	NULL
of	NULL
CD28	NULL
returned	NULL
to	NULL
preactivation	NULL
levels	NULL
between	NULL
72	NULL
and	NULL
96	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
(	NULL
1	NULL
,	NULL
6	NULL
)	NULL
,	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
induced	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
transient	NULL
down-regulation	NULL
of	NULL
CD28	NULL
and	NULL
in	NULL
site	NULL
a-	NULL
and	NULL
B-activities	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
CD28	NULL
cross-linking	NULL
on	NULL
CD28	NULL
expression	NULL
In	NULL
the	NULL
above	NULL
experiments	NULL
,	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
was	NULL
presumably	NULL
accomplished	NULL
by	NULL
the	NULL
simultaneous	NULL
engagement	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
and	NULL
CD28	NULL
by	NULL
OKT3	NULL
and	NULL
CD80/CD86	NULL
,	NULL
respectively	NULL
,	NULL
presented	NULL
on	NULL
monocytes	NULL
.	NULL

To	NULL
directly	NULL
assess	NULL
whether	NULL
these	NULL
observations	NULL
could	NULL
be	NULL
attributed	NULL
to	NULL
TCR-CD3	NULL
and/or	NULL
CD28	NULL
engagement	NULL
,	NULL
Ab	NULL
cross-linking	NULL
experiments	NULL
were	NULL
conducted	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
cultured	NULL
on	NULL
anti-mouse	NULL
Ig-coated	NULL
plates	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
anti-CD28	NULL
and	NULL
anti-CD3	NULL
(	NULL
OKT3	NULL
)	NULL
mAbs	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
cross-linking	NULL
of	NULL
CD3	NULL
with	NULL
or	NULL
without	NULL
co-cross-linking	NULL
of	NULL
CD28	NULL
induced	NULL
@	NULL
[	NULL
3	NULL
®	NULL
3	NULL
2	NULL
20	NULL
§	NULL
o	NULL
§§b§§§g§=§	NULL
E	NULL
$	NULL
#	NULL
3	NULL
&	NULL
B	NULL
$	NULL
%	NULL
©	NULL
«	NULL
uth	NULL
-	NULL
<	NULL
4	NULL
A	NULL
site	NULL
o.	NULL
site	NULL
B	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Site	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
in	NULL
somatic	NULL
tissues	NULL
.	NULL

Single-cell	NULL
suspensions	NULL
from	NULL
fresh	NULL
surgical	NULL
tissues	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
in	NULL
EMSAs	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Experiments	NULL
were	NULL
conducted	NULL
using	NULL
two	NULL
samples	NULL
of	NULL
nuclear	NULL
extracts	NULL
as	NULL
depicted	NULL
.	NULL

Representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

the	NULL
down-regulation	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

The	NULL
cross-linking	NULL
of	NULL
CD28	NULL
by	NULL
itself	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
cell	NULL
surface	NULL
density	NULL
of	NULL
CD28	NULL
.	NULL

An	NULL
analysis	NULL
of	NULL
«	NULL
-/B-binding	NULL
profiles	NULL
of	NULL
parallel	NULL
cultures	NULL
showed	NULL
that	NULL
cross-linking	NULL
of	NULL
CD3	NULL
alone	NULL
or	NULL
the	NULL
simultaneous	NULL
cross-linking	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
resulted	NULL
in	NULL
significant	NULL
reductions	NULL
of	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD28	NULL
cross-linking	NULL
alone	NULL
did	NULL
not	NULL
affect	NULL
&	NULL
-/B-activities	NULL
.	NULL

Modulation	NULL
of	NULL
CD28	NULL
expression	NULL
during	NULL
replicative	NULL
senescence	NULL
Loss	NULL
of	NULL
CD28	NULL
expression	NULL
on	NULL
T	NULL
lymphocytes	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
a	NULL
marker	NULL
of	NULL
replicative	NULL
senescence	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
relevant	NULL
for	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
show	NULL
increased	NULL
frequencies	NULL
of	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
cells	NULL
in	NULL
patients	NULL
with	NULL
chronic	NULL
infections	NULL
as	NULL
well	NULL
as	NULL
during	NULL
normal	NULL
aging	NULL
(	NULL
32-38	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
emergence	NULL
of	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
A	NULL
OKT3	NULL
_	NULL
unstimulated	NULL
F3	NULL
&	NULL
$	NULL
©	NULL
s	NULL
&	NULL
E	NULL
B	NULL
b	NULL
~	NULL
r	NULL
10°	NULL
10	NULL
'	NULL
10	NULL
108	NULL
CD28	NULL
expression	NULL
(	NULL
fluorescence	NULL
intensity	NULL
)	NULL
B	NULL
.	NULL

.	NULL

site	NULL
site	NULL
B	NULL
CD4t	NULL
CbDst	NULL
CD4t	NULL
Cbst	NULL
IgG	NULL
OKT3	NULL
IgG	NULL
OKT3	NULL
IgG	NULL
OKT3	NULL
IgG	NULL
OKT3	NULL
llis	NULL
,	NULL
Mims	NULL
FIGURE	NULL
5	NULL
.	NULL

Modulation	NULL
of	NULL
site	NULL
e-	NULL
and	NULL
B-bound	NULL
complexes	NULL
by	NULL
activating	NULL
stimuli	NULL
.	NULL

Short	NULL
term	NULL
CD28	NULL
*	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
incubated	NULL
with	NULL
freshly	NULL
isolated	NULL
autologous	NULL
monocytes	NULL
and	NULL
soluble	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
OKT3	NULL
)	NULL
or	NULL
mouse	NULL
IgG	NULL
for	NULL
24	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
«	NULL
and	NULL
B	NULL
oligonucleotide	NULL
probes	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Parallel	NULL
cultures	NULL
of	NULL
the	NULL
same	NULL
cell	NULL
line	NULL
were	NULL
monitored	NULL
for	NULL
CD28	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
A	NULL
)	NULL
and	NULL
for	NULL
«	NULL
-/B-binding	NULL
activities	NULL
by	NULL
EMSAs	NULL
(	NULL
B	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
conducted	NULL
with	NULL
replicate	NULL
binding	NULL
reactions	NULL
from	NULL
two	NULL
batches	NULL
of	NULL
nuclear	NULL
extracts	NULL
as	NULL
depicted	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
in	NULL
experiments	NULL
using	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Solid	NULL
lines	NULL
,	NULL
CD4	NULL
*	NULL
;	NULL
dotted	NULL
lines	NULL
,	NULL
CD8	NULL
*	NULL
;	NULL
shaded	NULL
curve	NULL
,	NULL
isotype	NULL
control	NULL
.	NULL

Me	NULL
,	NULL
monocytes	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6576	NULL
A	NULL
F3	NULL
5	NULL
8	NULL
G6	NULL
5	NULL
Fel	NULL
E	NULL
S	NULL
Z	NULL
l	NULL
u	NULL
a	NULL
T	NULL
T	NULL
U	NULL
10°	NULL
10	NULL
'	NULL
10°	NULL
10°	NULL
10+	NULL
CD28	NULL
expression	NULL
(	NULL
fluorescence	NULL
intensity	NULL
)	NULL
B	NULL
site	NULL
o	NULL
site	NULL
B	NULL
OKT3	NULL
OKT3	NULL
gG	NULL
OKT3	NULL
+282	NULL
282	NULL
G	NULL
OKT3	NULL
+282	NULL
282	NULL
FIGURE	NULL
6	NULL
.	NULL

CD28	NULL
cross-linking	NULL
does	NULL
not	NULL
affect	NULL
site	NULL
«	NULL
-	NULL
and	NULL
-binding	NULL
activities	NULL
.	NULL

Short	NULL
term	NULL
CD4~CD28*	NULL
T	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
on	NULL
anti-mouse	NULL
Ig-coated	NULL
plates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
Ab	NULL
(	NULL
28.2	NULL
)	NULL
,	NULL
anti-CD3	NULL
(	NULL
OKT3	NULL
)	NULL
,	NULL
or	NULL
mouse	NULL
IgG	NULL
for	NULL
24	NULL
h.	NULL
Parallel	NULL
cultures	NULL
of	NULL
the	NULL
same	NULL
cell	NULL
line	NULL
were	NULL
monitored	NULL
for	NULL
CD28	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
4	NULL
)	NULL
and	NULL
for	NULL
o-/B-binding	NULL
activities	NULL
by	NULL
EMSAs	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
(	NULL
B	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
conducted	NULL
with	NULL
replicate	NULL
binding	NULL
reactions	NULL
from	NULL
2	NULL
batches	NULL
of	NULL
nuclear	NULL
extracts	NULL
as	NULL
depicted	NULL
.	NULL

Data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
2	NULL
independent	NULL
experiments	NULL
.	NULL

Shaded	NULL
curve	NULL
-	NULL
isotype	NULL
control	NULL
.	NULL

cells	NULL
within	NULL
the	NULL
CD4	NULL
compartment	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
exception	NULL
rather	NULL
than	NULL
the	NULL
rule	NULL
(	NULL
11	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
of	NULL
CD28	NULL
down-regulation	NULL
during	NULL
replicative	NULL
senescence	NULL
,	NULL
CD4	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
,	NULL
activated	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
mAb	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
.	NULL

Before	NULL
in	NULL
vitro	NULL
activation	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
cells	NULL
in	NULL
the	NULL
purified	NULL
CD4	NULL
*	NULL
population	NULL
was	NULL
<	NULL
0.1	NULL
%	NULL
.	NULL

During	NULL
the	NULL
culture	NULL
period	NULL
of	NULL
12	NULL
wk	NULL
,	NULL
there	NULL
was	NULL
a	NULL
minimal	NULL
emergence	NULL
of	NULL
CD4	NULL
*CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
accounting	NULL
for	NULL
0.8	NULL
%	NULL
of	NULL
the	NULL
total	NULL
population	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
fresh	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
contained	NULL
between	NULL
33	NULL
%	NULL
and	NULL
48	NULL
%	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
.	NULL

There	NULL
was	NULL
also	NULL
a	NULL
minimal	NULL
increase	NULL
in	NULL
the	NULL
frequencies	NULL
of	NULL
these	NULL
cells	NULL
by	NULL
an	NULL
average	NULL
of	NULL
FIGURE	NULL
7	NULL
.	NULL

Modulation	NULL
of	NULL
site	NULL
B-binding	NULL
activities	NULL
in	NULL
long	NULL
term	NULL
T	NULL
cell	NULL
cultures	NULL
.	NULL

CD4*CD28*	NULL
and	NULL
CD8°CD28*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
a	NULL
healthy	NULL
donor	NULL
,	NULL
cultured	NULL
REGULATORY	NULL
MOTIFS	NULL
CONTROLLING	NULL
CD28	NULL
EXPRESSION	NULL
1	NULL
%	NULL
during	NULL
the	NULL
culture	NULL
period	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
12-wk	NULL
culture	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
allow	NULL
for	NULL
the	NULL
emergence	NULL
of	NULL
CD28	NULL
``	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
this	NULL
culture	NULL
period	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
clear	NULL
down-regulation	NULL
of	NULL
CD28	NULL
expression	NULL
that	NULL
was	NULL
more	NULL
pronounced	NULL
on	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
seen	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
with	NULL
purified	NULL
CD4*CD28*	NULL
and	NULL
CD8	NULL
``	NULL
CD28	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

During	NULL
the	NULL
12-week	NULL
culture	NULL
,	NULL
CD28	NULL
expression	NULL
on	NULL
CD4	NULL
*	NULL
cells	NULL
declined	NULL
from	NULL
a	NULL
mean	NULL
fluorescence	NULL
channel	NULL
of	NULL
260	NULL
to	NULL
192	NULL
.	NULL

In	NULL
CD8	NULL
*	NULL
cells	NULL
,	NULL
CD28	NULL
expression	NULL
declined	NULL
within	NULL
4	NULL
wk	NULL
with	NULL
48	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
showing	NULL
a	NULL
CD28	NULL
``	NULL
phenotype	NULL
.	NULL

By	NULL
12	NULL
wk	NULL
,	NULL
all	NULL
CD8	NULL
T	NULL
cells	NULL
had	NULL
a	NULL
reduced	NULL
CD28	NULL
expression	NULL
;	NULL
the	NULL
mean	NULL
fluorescence	NULL
channel	NULL
had	NULL
decreased	NULL
from	NULL
225	NULL
to	NULL
55	NULL
.	NULL

Cultured	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
site	NULL
a-and	NULL
-binding	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
there	NULL
was	NULL
a	NULL
dissociated	NULL
regulation	NULL
of	NULL
site	NULL
-	NULL
and	NULL
-binding	NULL
activities	NULL
.	NULL

Although	NULL
nuclear	NULL
factors	NULL
binding	NULL
to	NULL
site	NULL
«	NULL
were	NULL
maintained	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
during	NULL
the	NULL
culture	NULL
period	NULL
,	NULL
there	NULL
was	NULL
a	NULL
characteristic	NULL
pattern	NULL
of	NULL
loss	NULL
in	NULL
the	NULL
site	NULL
-binding	NULL
activities	NULL
.	NULL

As	NULL
already	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
CD4*CD28*	NULL
T	NULL
cells	NULL
showed	NULL
two	NULL
-bound	NULL
complexes	NULL
,	NULL
a	NULL
slow	NULL
migrating	NULL
B1	NULL
band	NULL
,	NULL
and	NULL
a	NULL
faster	NULL
migrating	NULL
B2	NULL
complex	NULL
.	NULL

Cultured	NULL
CD4	NULL
*	NULL
cells	NULL
showed	NULL
a	NULL
reduction	NULL
or	NULL
the	NULL
complete	NULL
loss	NULL
of	NULL
the	NULL
slower	NULL
migrating	NULL
B1	NULL
band	NULL
,	NULL
whereas	NULL
the	NULL
faster	NULL
migrating	NULL
B2	NULL
band	NULL
was	NULL
maintained	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
CD8	NULL
``	NULL
CD28	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
already	NULL
lacked	NULL
the	NULL
B1	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
that	NULL
was	NULL
lost	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
during	NULL
the	NULL
culture	NULL
period	NULL
.	NULL

The	NULL
culture	NULL
of	NULL
CD8	NULL
*	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
further	NULL
decline	NULL
of	NULL
the	NULL
faster	NULL
migrating	NULL
B2	NULL
band	NULL
.	NULL

This	NULL
loss	NULL
was	NULL
already	NULL
evident	NULL
after	NULL
4	NULL
wk	NULL
of	NULL
culture	NULL
,	NULL
and	NULL
a	NULL
significant	NULL
loss	NULL
of	NULL
binding	NULL
activity	NULL
was	NULL
seen	NULL
after	NULL
12	NULL
wk	NULL
.	NULL

Discussion	NULL
CD28	NULL
is	NULL
the	NULL
requisite	NULL
costimulatory	NULL
molecule	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
immune	NULL
responses	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
constitutively	NULL
expressed	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
CD28	NULL
may	NULL
be	NULL
entirely	NULL
absent	NULL
on	NULL
functional	NULL
T	NULL
cells	NULL
(	NULL
11	NULL
,	NULL
12	NULL
,	NULL
39-41	NULL
)	NULL
.	NULL

Variations	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
its	NULL
surface	NULL
expression	NULL
are	NULL
thought	NULL
to	NULL
have	NULL
a	NULL
major	NULL
impact	NULL
on	NULL
the	NULL
fine-tuning	NULL
of	NULL
immune	NULL
responses	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
13	NULL
,	NULL
42-45	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
understanding	NULL
the	NULL
exact	NULL
dynamics	NULL
of	NULL
CD28	NULL
regulation	NULL
is	NULL
of	NULL
paramount	NULL
importance	NULL
.	NULL

In	NULL
previous	NULL
work	NULL
(	NULL
11	NULL
)	NULL
,	NULL
we	NULL
mapped	NULL
two	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
minimal	NULL
CD28	NULL
gene	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
that	NULL
are	NULL
occupied	NULL
by	NULL
two	NULL
noncompeting	NULL
nuclear	NULL
factors	NULL
.	NULL

Both	NULL
motifs	NULL
,	NULL
site	NULL
«	NULL
and	NULL
B	NULL
,	NULL
are	NULL
located	NULL
downstream	NULL
from	NULL
the	NULL
TATA	NULL
box	NULL
.	NULL

The	NULL
central	NULL
contributions	NULL
cpat	NULL
cpst	NULL
Number	NULL
of	NULL
events	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
OKT3	NULL
)	NULL
and	NULL
exogenous	NULL
IL-2	NULL
,	NULL
and	NULL
subsequently	NULL
maintained	NULL
for	NULL
12	NULL
wk	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
parallel	NULL
cultures	NULL
were	NULL
monitored	NULL
for	NULL
CD28	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
A	NULL
)	NULL
and	NULL
B	NULL
for	NULL
o-/B-binding	NULL
EMSAs	NULL
(	NULL
B	NULL
)	NULL
.	NULL

EMSAs	NULL
were	NULL
conducted	NULL
with	NULL
replicate	NULL
binding	NULL
reactions	NULL
from	NULL
two	NULL
batches	NULL
of	NULL
nuclear	NULL
extracts	NULL
as	NULL
depicted	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

Solid	NULL
lines	NULL
,	NULL
freshly	NULL
isolated	NULL
cells	NULL
;	NULL
dashed	NULL
lines	NULL
,	NULL
4-wk	NULL
cell	NULL
lines	NULL
;	NULL
dotted	NULL
lines	NULL
,	NULL
12-wk	NULL
cell	NULL
lines	NULL
;	NULL
shaded	NULL
curve	NULL
,	NULL
isotype	NULL
control	NULL
.	NULL

CD4*	NULL
fresh	NULL
12	NULL
wk	NULL
10°	NULL
10°	NULL
10	NULL
102	NULL
10°	NULL
CD28	NULL
expression	NULL
(	NULL
fluorescence	NULL
intensity	NULL
)	NULL
site	NULL
site	NULL
B	NULL
cDst	NULL
Coat	NULL
cost	NULL
fresh	NULL
4wk	NULL
12	NULL
wk	NULL
fresh	NULL
12	NULL
wk	NULL
-	NULL
fresh	NULL
4	NULL
wk	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
of	NULL
these	NULL
sequences	NULL
in	NULL
CD28	NULL
expression	NULL
can	NULL
be	NULL
inferred	NULL
from	NULL
mu-tational	NULL
studies	NULL
that	NULL
demonstrated	NULL
the	NULL
loss	NULL
of	NULL
motif-specific	NULL
binding	NULL
activities	NULL
and	NULL
the	NULL
inactivation	NULL
of	NULL
the	NULL
minimal	NULL
promoter	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
phenotype	NULL
among	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
binding	NULL
activities	NULL
of	NULL
both	NULL
motifs	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
was	NULL
designed	NULL
to	NULL
investigate	NULL
how	NULL
sites	NULL
-	NULL
and	NULL
B-binding	NULL
activities	NULL
are	NULL
involved	NULL
in	NULL
modulating	NULL
CD28	NULL
expression	NULL
,	NULL
particularly	NULL
under	NULL
conditions	NULL
known	NULL
to	NULL
affect	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
expression	NULL
.	NULL

Data	NULL
presented	NULL
herein	NULL
provide	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
showing	NULL
that	NULL
the	NULL
dynamics	NULL
of	NULL
a-	NULL
and	NULL
-binding	NULL
activities	NULL
are	NULL
predictive	NULL
for	NULL
different	NULL
patterns	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

First	NULL
,	NULL
tissue	NULL
specificity	NULL
of	NULL
site	NULL
-	NULL
and	NULL
-bound	NULL
nuclear	NULL
factors	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
nuclear	NULL
factor	NULL
complexes	NULL
exclusively	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

2-4	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
CD28	NULL
expression	NULL
is	NULL
directly	NULL
correlated	NULL
with	NULL
the	NULL
highly	NULL
coordinated	NULL
expression	NULL
of	NULL
site	NULL
a-	NULL
and	NULL
-bound	NULL
nuclear	NULL
proteins	NULL
(	NULL
Figs	NULL
.	NULL

2-4	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
pathways	NULL
for	NULL
CD28	NULL
down-regulation	NULL
are	NULL
indicated	NULL
by	NULL
the	NULL
differential	NULL
binding	NULL
activities	NULL
of	NULL
a	NULL
and	NULL
B	NULL
sequences	NULL
(	NULL
Figs	NULL
.	NULL

5-7	NULL
)	NULL
.	NULL

These	NULL
pathways	NULL
occur	NULL
at	NULL
conditions	NULL
known	NULL
to	NULL
modulate	NULL
CD28	NULL
expression	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
transient	NULL
down-regulation	NULL
of	NULL
CD28	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
and	NULL
the	NULL
progressive	NULL
reduction	NULL
in	NULL
CD28	NULL
expression	NULL
that	NULL
is	NULL
characteristic	NULL
of	NULL
T	NULL
cells	NULL
during	NULL
replicative	NULL
senescence	NULL
.	NULL

The	NULL
notion	NULL
that	NULL
sites	NULL
«	NULL
and	NULL
B	NULL
play	NULL
a	NULL
role	NULL
in	NULL
CD28	NULL
expression	NULL
derives	NULL
from	NULL
the	NULL
data	NULL
showing	NULL
the	NULL
congruence	NULL
of	NULL
specific	NULL
motif-binding	NULL
activities	NULL
and	NULL
CD28	NULL
expression	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
,	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

These	NULL
activities	NULL
are	NULL
seen	NULL
in	NULL
both	NULL
CD4	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
B	NULL
cells	NULL
that	NULL
express	NULL
CD28	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
the	NULL
a-	NULL
and	NULL
-bound	NULL
proteins	NULL
represent	NULL
two	NULL
distinct	NULL
molecules	NULL
based	NULL
on	NULL
their	NULL
differences	NULL
in	NULL
gel	NULL
mobility	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
reciprocal	NULL
competition	NULL
the	NULL
two	NULL
sequence	NULL
motifs	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Preliminary	NULL
studies	NULL
on	NULL
the	NULL
isolation	NULL
of	NULL
the	NULL
a-	NULL
and	NULL
-bound	NULL
proteins	NULL
reveal	NULL
that	NULL
they	NULL
represent	NULL
~47-kDa	NULL
and	NULL
~39-kDa	NULL
molecules	NULL
,	NULL
respectively	NULL
(	NULL
A.	NULL
N.	NULL
Vallejo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
various	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
cells	NULL
,	NULL
including	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
clones	NULL
,	NULL
lack	NULL
any	NULL
detectable	NULL
«	NULL
-/-binding	NULL
activities	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
both	NULL
complexes	NULL
in	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
indicates	NULL
a	NULL
strong	NULL
correlation	NULL
between	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
both	NULL
DNA-binding	NULL
proteins	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
.	NULL

This	NULL
suggestion	NULL
is	NULL
consistent	NULL
with	NULL
data	NULL
from	NULL
point	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
a	NULL
or	NULL
B	NULL
motif	NULL
that	NULL
show	NULL
the	NULL
abrogation	NULL
of	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
CD28	NULL
promoter	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Data	NULL
presented	NULL
here	NULL
also	NULL
show	NULL
that	NULL
«	NULL
-/B-bound	NULL
complexes	NULL
are	NULL
found	NULL
only	NULL
in	NULL
lymphoid	NULL
tissues	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
they	NULL
are	NULL
both	NULL
gene-	NULL
and	NULL
tissue-specific	NULL
.	NULL

This	NULL
is	NULL
a	NULL
rather	NULL
unexpected	NULL
finding	NULL
because	NULL
it	NULL
is	NULL
not	NULL
uncommon	NULL
for	NULL
nuclear	NULL
factors	NULL
,	NULL
whether	NULL
they	NULL
are	NULL
activators	NULL
of	NULL
transcription	NULL
,	NULL
scaffold/architectural	NULL
proteins	NULL
,	NULL
or	NULL
basal	NULL
factors	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
different	NULL
genes	NULL
in	NULL
various	NULL
tissues	NULL
.	NULL

Whether	NULL
this	NULL
exclusivity	NULL
of	NULL
site	NULL
a-	NULL
and	NULL
-specific	NULL
nuclear	NULL
factors	NULL
to	NULL
lymphoid	NULL
tissue	NULL
is	NULL
attributed	NULL
to	NULL
single	NULL
motif-specific	NULL
binding	NULL
proteins	NULL
or	NULL
larger	NULL
tissue-specific	NULL
complexes	NULL
remains	NULL
to	NULL
be	NULL
examined	NULL
.	NULL

Whereas	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
site	NULL
«	NULL
-binding	NULL
activities	NULL
are	NULL
equivalent	NULL
in	NULL
all	NULL
CD28	NULL
*	NULL
cells	NULL
,	NULL
there	NULL
are	NULL
distinguishable	NULL
-binding	NULL
pro-files	NULL
.	NULL

CD4*CD28*	NULL
T	NULL
cells	NULL
generally	NULL
show	NULL
two	NULL
B-bound	NULL
complexes	NULL
(	NULL
B1	NULL
and	NULL
B2	NULL
)	NULL
,	NULL
CD28*	NULL
B	NULL
cells	NULL
and	NULL
CD8	NULL
*	NULL
CD28*	NULL
T	NULL
cells	NULL
show	NULL
a	NULL
single	NULL
band	NULL
,	NULL
B2	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

These	NULL
results	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
differential	NULL
requirement	NULL
of	NULL
the	NULL
B	NULL
complexes	NULL
for	NULL
CD28	NULL
transcription	NULL
in	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
CD28	NULL
*-transformed	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
B-binding	NULL
profiles	NULL
however	NULL
,	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
CD28	NULL
cell	NULL
surface	NULL
expression	NULL
.	NULL

Transformed	NULL
B	NULL
cells	NULL
have	NULL
extremely	NULL
low	NULL
levels	NULL
of	NULL
CD28	NULL
expression	NULL
when	NULL
compared	NULL
with	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

CD8	NULL
*	NULL
and	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
have	NULL
equivalent	NULL
cell	NULL
surface	NULL
densities	NULL
of	NULL
CD28	NULL
that	NULL
are	NULL
multifold	NULL
higher	NULL
compared	NULL
to	NULL
those	NULL
seen	NULL
on	NULL
plasmacytoma	NULL
cells	NULL
.	NULL

6577	NULL
The	NULL
significance	NULL
of	NULL
CD28	NULL
expression	NULL
on	NULL
B	NULL
cells	NULL
is	NULL
not	NULL
known	NULL
,	NULL
although	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
feature	NULL
of	NULL
plasmacytomas	NULL
,	NULL
but	NULL
not	NULL
of	NULL
primary	NULL
B	NULL
cells	NULL
(	NULL
46-48	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
work	NULL
,	NULL
we	NULL
also	NULL
report	NULL
that	NULL
some	NULL
,	NULL
but	NULL
not	NULL
all	NULL
,	NULL
EBV-transformed	NULL
lymphoblastoid	NULL
B	NULL
cells	NULL
express	NULL
CD28	NULL
.	NULL

Some	NULL
studies	NULL
suggest	NULL
that	NULL
this	NULL
may	NULL
provide	NULL
another	NULL
survival	NULL
advantage	NULL
for	NULL
immortalized	NULL
or	NULL
transformed	NULL
B	NULL
cells	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
coexpression	NULL
of	NULL
CD80	NULL
,	NULL
the	NULL
counterreceptor	NULL
for	NULL
CD28	NULL
,	NULL
on	NULL
the	NULL
same	NULL
B	NULL
cells	NULL
(	NULL
48	NULL
)	NULL
and	NULL
its	NULL
ability	NULL
to	NULL
generate	NULL
a	NULL
signaling	NULL
cascade	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Regardless	NULL
of	NULL
its	NULL
function	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
unusual	NULL
expression	NULL
of	NULL
CD28	NULL
on	NULL
these	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
acquisition	NULL
of	NULL
both	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
,	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
also	NULL
show	NULL
that	NULL
the	NULL
site	NULL
«	NULL
and	NULL
B	NULL
binding	NULL
activities	NULL
influence	NULL
the	NULL
fine-tuning	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

Activating	NULL
stimuli	NULL
induce	NULL
a	NULL
transient	NULL
reduction	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
accompanied	NULL
by	NULL
the	NULL
coordinate	NULL
down-regulation	NULL
of	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Continuous	NULL
culture	NULL
of	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
B-	NULL
but	NULL
not	NULL
-binding	NULL
activities	NULL
that	NULL
is	NULL
accompanied	NULL
by	NULL
a	NULL
progressive	NULL
decrease	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Down-regulation	NULL
of	NULL
CD28	NULL
expression	NULL
following	NULL
T	NULL
cell	NULL
activation	NULL
is	NULL
well	NULL
documented	NULL
(	NULL
1	NULL
,	NULL
6	NULL
,	NULL
13	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
,	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
,	NULL
or	NULL
mitogenic	NULL
agents	NULL
such	NULL
as	NULL
PMA/ionomycin	NULL
induce	NULL
significant	NULL
reductions	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
CD28	NULL
cell	NULL
surface	NULL
expression	NULL
.	NULL

These	NULL
are	NULL
accompanied	NULL
by	NULL
the	NULL
down-regulation	NULL
of	NULL
both	NULL
site	NULL
a-	NULL
and	NULL
B-binding	NULL
activities	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD28	NULL
alone	NULL
did	NULL
not	NULL
affect	NULL
CD28	NULL
expression	NULL
or	NULL
a-/B-activities	NULL
,	NULL
indicating	NULL
that	NULL
modulation	NULL
of	NULL
CD28	NULL
expression	NULL
is	NULL
directly	NULL
influenced	NULL
by	NULL
activation	NULL
signals	NULL
emanating	NULL
from	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
.	NULL

These	NULL
data	NULL
corroborate	NULL
previous	NULL
studies	NULL
showing	NULL
activation-induced	NULL
down-modulation	NULL
of	NULL
CD28	NULL
gene	NULL
promoter	NULL
activity	NULL
(	NULL
11	NULL
)	NULL
.	NULL

They	NULL
are	NULL
also	NULL
consistent	NULL
with	NULL
other	NULL
studies	NULL
demonstrating	NULL
the	NULL
rapid	NULL
and	NULL
selective	NULL
reduction	NULL
in	NULL
the	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
CD28	NULL
mRNA	NULL
following	NULL
activation	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
observations	NULL
indicate	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
regulatory	NULL
pathway	NULL
that	NULL
specifically	NULL
targets	NULL
the	NULL
down-regulation	NULL
of	NULL
CD28	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
characteristic	NULL
reduction	NULL
in	NULL
both	NULL
a-	NULL
and	NULL
-binding	NULL
activities	NULL
following	NULL
activation	NULL
strongly	NULL
support	NULL
this	NULL
hypothesis	NULL
.	NULL

The	NULL
functional	NULL
impact	NULL
of	NULL
CD28	NULL
down-regulation	NULL
in	NULL
T	NULL
cell-mediated	NULL
responses	NULL
remains	NULL
to	NULL
be	NULL
explored	NULL
.	NULL

However	NULL
,	NULL
receptor	NULL
down-regulation	NULL
of	NULL
the	NULL
TCR	NULL
complex	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
50-54	NULL
)	NULL
.	NULL

This	NULL
is	NULL
thought	NULL
to	NULL
effectively	NULL
reduce	NULL
the	NULL
avidity	NULL
of	NULL
receptor-ligand	NULL
inter-actions	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
T	NULL
cell	NULL
effector	NULL
functions	NULL
.	NULL

Hence	NULL
,	NULL
variations	NULL
in	NULL
CD28	NULL
expression	NULL
may	NULL
influence	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
costimulatory	NULL
signal	NULL
that	NULL
determines	NULL
whether	NULL
T	NULL
cells	NULL
undergo	NULL
proliferation	NULL
or	NULL
anergy	NULL
(	NULL
1-10	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
reduction	NULL
in	NULL
CD28	NULL
expression	NULL
following	NULL
activation	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
increased	NULL
susceptibility	NULL
to	NULL
Fas-induced	NULL
apoptosis	NULL
(	NULL
10	NULL
,	NULL
45	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
importance	NULL
of	NULL
receptor	NULL
modulation	NULL
in	NULL
maintaining	NULL
T	NULL
cell	NULL
homeostasis	NULL
.	NULL

While	NULL
activation-induced	NULL
down-regulation	NULL
of	NULL
CD28	NULL
expression	NULL
equally	NULL
affected	NULL
CD4*	NULL
and	NULL
CD8	NULL
#	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
gradual	NULL
loss	NULL
of	NULL
CD28	NULL
expression	NULL
during	NULL
continuous	NULL
culture	NULL
was	NULL
more	NULL
pronounced	NULL
in	NULL
the	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
type	NULL
of	NULL
cell	NULL
culture	NULL
has	NULL
been	NULL
proposed	NULL
as	NULL
a	NULL
model	NULL
of	NULL
replicative	NULL
senescence	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
55	NULL
)	NULL
and	NULL
mimics	NULL
the	NULL
characteristic	NULL
increase	NULL
in	NULL
the	NULL
frequencies	NULL
of	NULL
CD8	NULL
~CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
during	NULL
aging	NULL
or	NULL
chronic	NULL
infections	NULL
(	NULL
14	NULL
,	NULL
31-35	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
CD8	NULL
``	NULL
CD28	NULL
``	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
significantly	NULL
shorter	NULL
telomeres	NULL
compared	NULL
with	NULL
CD8	NULL
T	NULL
cells	NULL
(	NULL
56	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
are	NULL
infrequent	NULL
and	NULL
are	NULL
found	NULL
only	NULL
in	NULL
some	NULL
elderly	NULL
individuals	NULL
and	NULL
among	NULL
RA	NULL
patients	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
either	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
higher	NULL
turnover	NULL
compared	NULL
with	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6578	NULL
CD4*	NULL
T	NULL
cells	NULL
or	NULL
that	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
high	NULL
propensity	NULL
of	NULL
losing	NULL
CD28	NULL
expression	NULL
.	NULL

Data	NULL
presented	NULL
here	NULL
support	NULL
the	NULL
later	NULL
hypothesis	NULL
.	NULL

Continuous	NULL
culture	NULL
of	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
more	NULL
rapid	NULL
decline	NULL
in	NULL
CD28	NULL
expression	NULL
on	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
than	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
reduction	NULL
of	NULL
€D28	NULL
expression	NULL
on	NULL
T	NULL
cells	NULL
during	NULL
continuous	NULL
culture	NULL
is	NULL
correlated	NULL
with	NULL
changes	NULL
in	NULL
the	NULL
-binding	NULL
profiles	NULL
while	NULL
the	NULL
a	NULL
profile	NULL
is	NULL
maintained	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
7B	NULL
)	NULL
.	NULL

While	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
have	NULL
two	NULL
B-bound	NULL
complexes	NULL
,	NULL
B1	NULL
and	NULL
B2	NULL
,	NULL
cultured	NULL
CD4	NULL
``	NULL
CD28	NULL
*	NULL
T	NULL
cells	NULL
lose	NULL
the	NULL
B1	NULL
but	NULL
not	NULL
the	NULL
B2	NULL
complex	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
generally	NULL
exhibit	NULL
only	NULL
the	NULL
B2	NULL
complex	NULL
,	NULL
gradually	NULL
lost	NULL
this	NULL
complex	NULL
during	NULL
continuous	NULL
culture	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
regulation	NULL
of	NULL
CD28	NULL
expression	NULL
in	NULL
CD4	NULL
*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
B-binding	NULL
profiles	NULL
and	NULL
that	NULL
this	NULL
difference	NULL
may	NULL
be	NULL
related	NULL
to	NULL
the	NULL
progressive	NULL
loss	NULL
of	NULL
CD28	NULL
expression	NULL
during	NULL
replicative	NULL
senescence	NULL
in	NULL
vitro	NULL
.	NULL

Although	NULL
the	NULL
T	NULL
cell	NULL
culture	NULL
system	NULL
showed	NULL
the	NULL
down-regulation	NULL
of	NULL
CD28	NULL
,	NULL
a	NULL
complete	NULL
loss	NULL
of	NULL
CD28	NULL
expression	NULL
and	NULL
the	NULL
emergence	NULL
of	NULL
CD8	NULL
or	NULL
CD4TCD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
was	NULL
not	NULL
achieved	NULL
.	NULL

This	NULL
is	NULL
in	NULL
marked	NULL
contrast	NULL
with	NULL
the	NULL
in	NULL
vivo	NULL
situation	NULL
where	NULL
T	NULL
cells	NULL
completely	NULL
lose	NULL
the	NULL
expression	NULL
of	NULL
CD28	NULL
,	NULL
and	NULL
CD28	NULL
``	NULL
°	NULL
``	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
observed	NULL
(	NULL
11	NULL
,	NULL
32-36	NULL
)	NULL
.	NULL

As	NULL
the	NULL
data	NULL
show	NULL
,	NULL
CD4	NULL
CD28	NULL
``	NULL
and	NULL
CD8	NULL
T	NULL
cells	NULL
freshly	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
lack	NULL
both	NULL
a-	NULL
and	NULL
B-bound	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

This	NULL
is	NULL
unlike	NULL
in	NULL
vitro	NULL
replicative	NULL
senescence	NULL
wherein	NULL
site	NULL
B-	NULL
but	NULL
not	NULL
site	NULL
«	NULL
-binding	NULL
activity	NULL
is	NULL
down-modulated	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
activation	NULL
results	NULL
in	NULL
the	NULL
down-regulation	NULL
of	NULL
both	NULL
a-	NULL
and	NULL
-binding	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
continuous	NULL
activation	NULL
in	NULL
vivo	NULL
,	NULL
rather	NULL
than	NULL
replicative	NULL
immunosenescence	NULL
,	NULL
may	NULL
account	NULL
for	NULL
the	NULL
emergence	NULL
of	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
.	NULL

CD4*CD28	NULL
``	NULL
``	NULL
``	NULL
T	NULL
cells	NULL
are	NULL
highly	NULL
oligoclonal	NULL
(	NULL
57	NULL
,	NULL
58	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
may	NULL
be	NULL
derived	NULL
from	NULL
the	NULL
chronic	NULL
activation	NULL
and	NULL
proliferation	NULL
of	NULL
their	NULL
CD28	NULL
progenitors	NULL
.	NULL

This	NULL
interpretation	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
isolation	NULL
of	NULL
T	NULL
cell	NULL
clones	NULL
with	NULL
identical	NULL
TCR	NULL
B-chain	NULL
sequences	NULL
in	NULL
both	NULL
CD28*	NULL
and	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
subsets	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
CD28	NULL
expression	NULL
could	NULL
be	NULL
a	NULL
mechanism	NULL
to	NULL
reestablish	NULL
nonresponsiveness	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
under	NULL
conditions	NULL
of	NULL
continuous	NULL
antigenic	NULL
stimulation	NULL
.	NULL

This	NULL
suggestion	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
high	NULL
frequencies	NULL
of	NULL
CD4	NULL
``	NULL
CD28	NULL
``	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
chronic	NULL
inflammatory	NULL
disease	NULL
RA	NULL
(	NULL
12	NULL
,	NULL
59	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
data	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
the	NULL
dynamics	NULL
of	NULL
the	NULL
binding	NULL
profiles	NULL
of	NULL
the	NULL
a	NULL
and	NULL
B	NULL
sequence	NULL
motifs	NULL
in	NULL
the	NULL
CD28	NULL
gene	NULL
promoter	NULL
correlate	NULL
with	NULL
the	NULL
patterns	NULL
of	NULL
expression	NULL
of	NULL
CD28	NULL
.	NULL

Both	NULL
motif-specific	NULL
binding	NULL
activities	NULL
are	NULL
restricted	NULL
to	NULL
lymphoid	NULL
tissues	NULL
and	NULL
are	NULL
modulated	NULL
by	NULL
activating	NULL
stimuli	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
a-	NULL
and	NULL
-bound	NULL
complexes	NULL
are	NULL
coordinately	NULL
expressed	NULL
.	NULL

However	NULL
,	NULL
this	NULL
coordinate	NULL
expression	NULL
is	NULL
not	NULL
maintained	NULL
during	NULL
in	NULL
vitro	NULL
replicative	NULL
senescence	NULL
.	NULL

Among	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
,	NULL
continuous	NULL
culture	NULL
induces	NULL
the	NULL
selective	NULL
diminution	NULL
of	NULL
the	NULL
B-protein	NULL
complex	NULL
with	NULL
a	NULL
concurrent	NULL
decrease	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
CD28	NULL
.	NULL

Changes	NULL
in	NULL
CD4*	NULL
T	NULL
cells	NULL
are	NULL
less	NULL
pronounced	NULL
with	NULL
the	NULL
selective	NULL
loss	NULL
of	NULL
one	NULL
of	NULL
the	NULL
two	NULL
B-bound	NULL
complexes	NULL
accompanied	NULL
by	NULL
a	NULL
slight	NULL
,	NULL
but	NULL
significant	NULL
,	NULL
down-regulation	NULL
of	NULL
CD28	NULL
expression	NULL
.	NULL

The	NULL
complete	NULL
loss	NULL
of	NULL
function	NULL
in	NULL
both	NULL
motifs	NULL
is	NULL
correlated	NULL
with	NULL
a	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
phenotype	NULL
of	NULL
both	NULL
CD4*	NULL
and	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Although	NULL
both	NULL
activation	NULL
and	NULL
replicative	NULL
senescence	NULL
modulate	NULL
CD28	NULL
expression	NULL
,	NULL
further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
determine	NULL
which	NULL
mechanism	NULL
leads	NULL
to	NULL
the	NULL
CD28	NULL
``	NULL
``	NULL
``	NULL
endpoint	NULL
phenotype	NULL
observed	NULL
in	NULL
vivo	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
motif-specific	NULL
complexes	NULL
will	NULL
be	NULL
critical	NULL
to	NULL
our	NULL
further	NULL
understanding	NULL
of	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
CD28	NULL
expression	NULL
and	NULL
its	NULL
modulation	NULL
during	NULL
adaptive	NULL
immune	NULL
responses	NULL
that	NULL
led	NULL
to	NULL
the	NULL
development	NULL
of	NULL
CD28	NULL
``	NULL
T	NULL
cells	NULL
.	NULL

REGULATORY	NULL
MOTIFS	NULL
CONTROLLING	NULL
CD28	NULL
EXPRESSION	NULL
Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
Johannes	NULL
Bjérnsson	NULL
(	NULL
Department	NULL
of	NULL
Laboratory	NULL
Medicine	NULL
and	NULL
Pathology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
)	NULL
for	NULL
his	NULL
assistance	NULL
in	NULL
procuring	NULL
the	NULL
surgical	NULL
tissue	NULL
specimens	NULL
,	NULL
Drs	NULL
.	NULL

Diane	NULL
Jelinek	NULL
and	NULL
Paul	NULL
Leibson	NULL
(	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
)	NULL
for	NULL
providing	NULL
some	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
James	NULL
W.	NULL
Fulbright	NULL
and	NULL
Toni	NULL
L.	NULL
Higgins	NULL
for	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
co-stimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233	NULL
.	NULL

2	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
G.	NULL
1996	NULL
.	NULL

CD28	NULL
:	NULL
a	NULL
signaling	NULL
perspective	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

318:331	NULL
.	NULL

3	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
A.	NULL
J.	NULL
Minn	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
M.	NULL
Accavitti	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
co-stimulation	NULL
can	NULL
promote	NULL
T	NULL
cell	NULL
survival	NULL
by	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
Bcl-xL	NULL
.	NULL

Immunity	NULL
3:87	NULL
.	NULL

4	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
S.	NULL
L.	NULL
Kunkel	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
S.	NULL
G.	NULL
Emerson	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
June	NULL
.	NULL

1989	NULL
.	NULL

CD28	NULL
activation	NULL
pathway	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
multiple	NULL
T	NULL
cell-derived	NULL
lymphokines/cytokines	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:1333	NULL
.	NULL

5	NULL
.	NULL

McArthur	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Raulet	NULL
.	NULL

1993	NULL
.	NULL

CD28-induced	NULL
co-stimulation	NULL
of	NULL
T	NULL
helper	NULL
type	NULL
2	NULL
cells	NULL
mediated	NULL
by	NULL
induction	NULL
of	NULL
responsiveness	NULL
to	NULL
interleukin	NULL
4	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1645	NULL
.	NULL

6	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
during	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
antigen	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:191	NULL
.	NULL

7	NULL
.	NULL

Harding	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
MacArthur	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
H.	NULL
Raulet	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1992	NULL
.	NULL

CD28-mediated	NULL
signaling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T-cell	NULL
clones	NULL
.	NULL

Nature	NULL
356:607	NULL
.	NULL

8	NULL
.	NULL

Shahinian	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Pfeffer	NULL
,	NULL
K.	NULL
P.	NULL
Lee	NULL
,	NULL
T.	NULL
M.	NULL
Kundig	NULL
,	NULL
K.	NULL
Kishibara	NULL
,	NULL
A.	NULL
Wakeham	NULL
,	NULL
K.	NULL
Kawai	NULL
,	NULL
P.	NULL
S.	NULL
Ohashi	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
T	NULL
cell	NULL
co-stimulatory	NULL
requirements	NULL
in	NULL
CD28-deficient	NULL
mice	NULL
.	NULL

Science	NULL
267:609	NULL
.	NULL

9	NULL
.	NULL

Corry	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
S.	NULL
L.	NULL
Reiner	NULL
,	NULL
P.	NULL
S.	NULL
Linsley	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Locksley	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
blockade	NULL
of	NULL
CD28-B7	NULL
on	NULL
the	NULL
development	NULL
of	NULL
Th1	NULL
or	NULL
Th2	NULL
effector	NULL
cells	NULL
in	NULL
experimental	NULL
leishmaniasis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:4142	NULL
.	NULL

10	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
P.	NULL
J.	NULL
Noel	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1995	NULL
.	NULL

CD28	NULL
and	NULL
apoptosis	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:620	NULL
.	NULL

11	NULL
.	NULL

Vallejo	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
A.	NULL
R.	NULL
Nestel	NULL
,	NULL
M.	NULL
Schirmer	NULL
,	NULL
C.	NULL
M.	NULL
Weyand	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Goronzy	NULL
.	NULL

1998	NULL
.	NULL

Aging-related	NULL
deficiency	NULL
of	NULL
CD28	NULL
expression	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
gene-specific	NULL
nuclear	NULL
factor	NULL
binding	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:8119	NULL
.	NULL

12	NULL
.	NULL

Schmidt	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
J.	NULL
Goronzy	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Weyand	NULL
.	NULL

1996	NULL
.	NULL

CD4*	NULL
CD7~	NULL
CD28~	NULL
T	NULL
cells	NULL
are	NULL
expanded	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
are	NULL
characterized	NULL
by	NULL
auto-reactiv-ity	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

97:2027	NULL
.	NULL

13	NULL
.	NULL

Eck	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
D.	NULL
Chang	NULL
,	NULL
A.	NULL
D.	NULL
Wells	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Turka	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
down-regulation	NULL
of	NULL
CD28	NULL
by	NULL
B7-1	NULL
and	NULL
B7-2	NULL
engagement	NULL
.	NULL

Transplantation	NULL
64:1497	NULL
.	NULL

14	NULL
.	NULL

Effros	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
N.	NULL
Boucher	NULL
,	NULL
V.	NULL
Porter	NULL
,	NULL
X.	NULL
Zhu	NULL
,	NULL
C.	NULL
Spaulding	NULL
,	NULL
R.	NULL
L.	NULL
Walford	NULL
,	NULL
M.	NULL
Kroneneberg	NULL
,	NULL
D.	NULL
Cohen	NULL
,	NULL
and	NULL
F.	NULL
Schachter	NULL
.	NULL

1994	NULL
.	NULL

Decline	NULL
in	NULL
CD28	NULL
*	NULL
T	NULL
cells	NULL
in	NULL
centenarians	NULL
and	NULL
in	NULL
long	NULL
term	NULL
T	NULL
cell	NULL
cultures	NULL
:	NULL
a	NULL
possible	NULL
cause	NULL
for	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
immunosenescence	NULL
.	NULL

Exp	NULL
.	NULL

Gerontol	NULL
.	NULL

29:601	NULL
.	NULL

15	NULL
.	NULL

Effros	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

1997	NULL
.	NULL

Loss	NULL
of	NULL
CD28	NULL
expression	NULL
on	NULL
T	NULL
lymphocytes	NULL
:	NULL
a	NULL
marker	NULL
of	NULL
replicative	NULL
senescence	NULL
.	NULL

Dev	NULL
.	NULL

Comp	NULL
.	NULL

Immunol	NULL
.	NULL

21:471	NULL
.	NULL

16	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
J.	NULL
Ledbetter	NULL
,	NULL
R.	NULL
Peach	NULL
,	NULL
and	NULL
J.	NULL
Bajorath	NULL
.	NULL

1995	NULL
.	NULL

CD2§/CTLA-4	NULL
receptor	NULL
structure	NULL
,	NULL
binding	NULL
stoichiometry	NULL
and	NULL
aggregation	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

Res	NULL
.	NULL

Immunol	NULL
.	NULL

146:130	NULL
.	NULL

17	NULL
.	NULL

Kariv	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Trunch	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Sweet	NULL
.	NULL

1996	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
site	NULL
of	NULL
interaction	NULL
of	NULL
CD28	NULL
with	NULL
its	NULL
counter-receptors	NULL
CD80	NULL
and	NULL
CD86	NULL
and	NULL
correlation	NULL
with	NULL
func-tion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:29	NULL
.	NULL

18	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
J.	NULL
L.	NULL
Greene	NULL
,	NULL
W.	NULL
Brady	NULL
,	NULL
J.	NULL
Bajorath	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
and	NULL
R.	NULL
Peach	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
B7-1	NULL
(	NULL
CD80	NULL
)	NULL
and	NULL
B7-2	NULL
(	NULL
CD86	NULL
)	NULL
bind	NULL
with	NULL
similar	NULL
avidities	NULL
but	NULL
distinct	NULL
kinetics	NULL
to	NULL
CD28	NULL
and	NULL
CTLA-4	NULL
receptors	NULL
.	NULL

Immunity	NULL
1:793	NULL
.	NULL

19	NULL
.	NULL

Greene	NULL
,	NULL
J.	NULL
L..	NULL
,	NULL
G.	NULL
M.	NULL
Leytze	NULL
,	NULL
J.	NULL
Emswiler	NULL
,	NULL
R.	NULL
Peach	NULL
,	NULL
J.	NULL
Bajorath	NULL
,	NULL
W.	NULL
Cosand	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Linsley	NULL
.	NULL

1996	NULL
.	NULL

Covalent	NULL
dimerization	NULL
of	NULL
CD28/CTLA-4	NULL
and	NULL
oligomerization	NULL
of	NULL
CD80/CD86	NULL
regulate	NULL
T	NULL
cell	NULL
co-stimulatory	NULL
interactions	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
26762	NULL
.	NULL

20.	NULL
van	NULL
der	NULL
Merwe	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
D.	NULL
L.	NULL
Bodian	NULL
,	NULL
S.	NULL
Daenke	NULL
,	NULL
P.	NULL
Linsley	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Davis	NULL
.	NULL

1997	NULL
.	NULL

CD80	NULL
(	NULL
B7-1	NULL
)	NULL
binds	NULL
both	NULL
CD28	NULL
and	NULL
CTLA-4	NULL
with	NULL
a	NULL
low	NULL
affinity	NULL
and	NULL
very	NULL
fast	NULL
kinetics	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:393	NULL
.	NULL

21	NULL
.	NULL

Goronzy	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
P.	NULL
Bartz-Bazzanella	NULL
,	NULL
W.	NULL
Hu	NULL
,	NULL
M.	NULL
C.	NULL
Jendro	NULL
,	NULL
D.	NULL
R.	NULL
Walser-Kuntz	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Weyand	NULL
.	NULL

1994	NULL
.	NULL

Dominant	NULL
clonotypes	NULL
in	NULL
the	NULL
repertoire	NULL
of	NULL
peripheral	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:2068	NULL
.	NULL

22	NULL
.	NULL

Park	NULL
,	NULL
W.	NULL
,	NULL
C.	NULL
M.	NULL
Weyand	NULL
,	NULL
D.	NULL
Schmidt	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Goronzy	NULL
.	NULL

1997	NULL
.	NULL

Co-stimulatory	NULL
pathways	NULL
controlling	NULL
activation	NULL
and	NULL
peripheral	NULL
tolerance	NULL
of	NULL
human	NULL
CD4*CD28~	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:1082	NULL
.	NULL

23	NULL
.	NULL

Weyand	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
J.	NULL
C.	NULL
Brandes	NULL
,	NULL
D.	NULL
Schmidt	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Goronzy	NULL
.	NULL

1998	NULL
.	NULL

Functional	NULL
properties	NULL
of	NULL
CD4*	NULL
CD28~	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
aging	NULL
immune	NULL
system	NULL
.	NULL

Mech	NULL
.	NULL

Ageing	NULL
Dev	NULL
.	NULL

102:131	NULL
.	NULL

24	NULL
.	NULL

Schirmer	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
N.	NULL
Vallejo	NULL
,	NULL
C.	NULL
M.	NULL
Weyand	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Goronzy	NULL
.	NULL

1998	NULL
.	NULL

Resistance	NULL
to	NULL
apoptosis	NULL
and	NULL
elevated	NULL
expression	NULL
of	NULL
Bel-2	NULL
in	NULL
clonally	NULL
expanded	NULL
CD4	NULL
*	NULL
CD28~	NULL
T	NULL
cells	NULL
from	NULL
rheumatoid	NULL
arthritis	NULL
patients	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1018	NULL
.	NULL

25	NULL
.	NULL

Jelinek	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
G.	NULL
J.	NULL
Abmann	NULL
,	NULL
P.	NULL
R.	NULL
Greipp	NULL
,	NULL
S.	NULL
M.	NULL
Jalal	NULL
,	NULL
J.	NULL
J.	NULL
Westendorf	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Katzmann	NULL
,	NULL
R.	NULL
A.	NULL
Kyle	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Lust	NULL
.	NULL

1993	NULL
.	NULL

Coexistence	NULL
of	NULL
aneuploid	NULL
subclones	NULL
within	NULL
a	NULL
multiple	NULL
myeloma	NULL
cell	NULL
line	NULL
that	NULL
exhibits	NULL
clonal	NULL
immunoglob-ulin	NULL
gene	NULL
rearrangement	NULL
:	NULL
clinical	NULL
implications	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

53:5320	NULL
.	NULL

26	NULL
.	NULL

Westendorf	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
G.	NULL
J.	NULL
Abmann	NULL
,	NULL
P.	NULL
R.	NULL
Greipp	NULL
,	NULL
T.	NULL
E.	NULL
Witzig	NULL
,	NULL
R.	NULL
A.	NULL
Kyle	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Lust	NULL
,	NULL
and	NULL
D.	NULL
F.	NULL
Jelinek	NULL
.	NULL

1996	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
three	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42.	NULL
myeloma	NULL
cell	NULL
lines	NULL
that	NULL
demonstrate	NULL
variable	NULL
cytokine	NULL
responses	NULL
and	NULL
abilities	NULL
to	NULL
produce	NULL
autocrine	NULL
interleukin-6	NULL
.	NULL

Leukemia	NULL
10:866	NULL
.	NULL

Vallejo	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
and	NULL
L.	NULL
R.	NULL
Pease	NULL
.	NULL

1995	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
MHC	NULL
A	NULL
and	NULL
B	NULL
locus	NULL
promoters	NULL
in	NULL
hominoids	NULL
:	NULL
insights	NULL
on	NULL
the	NULL
evolution	NULL
of	NULL
the	NULL
class	NULL
I	NULL
MHC	NULL
multigene	NULL
family	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:3912	NULL
.	NULL

Aruffo	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1987	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
a	NULL
CD28	NULL
cDNA	NULL
by	NULL
a	NULL
high-efficiency	NULL
COS	NULL
cell	NULL
expression	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:8573	NULL
.	NULL

Lee	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
C.	NULL
Taylor	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
L.	NULL
A.	NULL
Turka	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
genomic	NULL
organization	NULL
of	NULL
the	NULL
CD28	NULL
gene	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
CD28	NULL
mRNA	NULL
expression	NULL
and	NULL
heterogeneity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:344	NULL
.	NULL

Vallejo	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
and	NULL
L.	NULL
R.	NULL
Pease	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
locus-specific	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
interferon-responsive	NULL
element	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
y-interferon	NULL
(	NULL
IFN	NULL
)	NULL
-inducible	NULL
factor	NULL
distinct	NULL
from	NULL
STAT1	NULL
«	NULL
@	NULL
,	NULL
p48	NULL
,	NULL
and	NULL
IFN	NULL
regulatory	NULL
factor-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:29813	NULL
.	NULL

Brunn	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
E.	NULL
L.	NULL
Falls	NULL
,	NULL
A.	NULL
E.	NULL
Nilson	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Abraham	NULL
.	NULL

1995	NULL
.	NULL

Protein-tyrosine	NULL
kinase-dependent	NULL
activation	NULL
of	NULL
STAT	NULL
transcription	NULL
factors	NULL
in	NULL
interleukin-2-	NULL
or	NULL
interleukin-4-stimulated	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11628	NULL
.	NULL

Fagnoni	NULL
,	NULL
F.	NULL
F.	NULL
,	NULL
R.	NULL
Vescovini	NULL
,	NULL
M.	NULL
Mazzola	NULL
,	NULL
G.	NULL
Bologna	NULL
,	NULL
E.	NULL
Nigro	NULL
,	NULL
G.	NULL
Lavagetto	NULL
,	NULL
C.	NULL
Franceschi	NULL
,	NULL
M.	NULL
Passeri	NULL
,	NULL
and	NULL
P.	NULL
Sansoni	NULL
.	NULL

1996	NULL
.	NULL

Expansion	NULL
of	NULL
cytotoxic	NULL
CD8	NULL
``	NULL
CD28~	NULL
T	NULL
cells	NULL
in	NULL
healthy	NULL
ageing	NULL
people	NULL
including	NULL
centenarians	NULL
.	NULL

Immunology	NULL
88	NULL
:	NULL
501	NULL
.	NULL

Merino	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
A.	NULL
Martinez-Gonzalez	NULL
,	NULL
M.	NULL
Rubio	NULL
,	NULL
S.	NULL
Inoges	NULL
,	NULL
A.	NULL
Sanchez-Ibarrola	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Subira	NULL
.	NULL

1998	NULL
.	NULL

Progressive	NULL
decrease	NULL
in	NULL
CD8high	NULL
``	NULL
CD28	NULL
*CD57~	NULL
cells	NULL
with	NULL
ageing	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

112:48	NULL
.	NULL

Borthwick	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
K.	NULL
Bofill	NULL
,	NULL
I.	NULL
Hassan	NULL
,	NULL
P.	NULL
Panayiotidis	NULL
,	NULL
G.	NULL
Janossy	NULL
,	NULL
M.	NULL
Salmon	NULL
,	NULL
and	NULL
A.	NULL
N.	NULL
Akbar	NULL
.	NULL

1996	NULL
.	NULL

Factors	NULL
that	NULL
influence	NULL
activated	NULL
CD8	NULL
*	NULL
T	NULL
cell	NULL
apoptosis	NULL
in	NULL
patients	NULL
with	NULL
acute	NULL
herpesvirus	NULL
infections	NULL
:	NULL
loss	NULL
of	NULL
co-stimulatory	NULL
molecules	NULL
CD28	NULL
,	NULL
CDS	NULL
and	NULL
CD6	NULL
but	NULL
relative	NULL
maintenance	NULL
of	NULL
Bax	NULL
and	NULL
Bcl-x	NULL
expression	NULL
.	NULL

Immunology	NULL
88:508	NULL
.	NULL

Hazzan	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Labelette	NULL
,	NULL
C.	NULL
Noel	NULL
,	NULL
G.	NULL
Lelievre	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Dessaint	NULL
.	NULL

1997	NULL
.	NULL

Recall	NULL
response	NULL
to	NULL
cytomegalovirus	NULL
in	NULL
allograft	NULL
recipients	NULL
:	NULL
mobilization	NULL
of	NULL
CDS7*	NULL
CD28	NULL
*	NULL
cells	NULL
before	NULL
the	NULL
expansion	NULL
of	NULL
CD57	NULL
``	NULL
CD28~	NULL
cells	NULL
within	NULL
the	NULL
CD8	NULL
*	NULL
T	NULL
lymphocyte	NULL
compartment	NULL
.	NULL

Transplantation	NULL
63:693	NULL
.	NULL

Caruso	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Licenziati	NULL
,	NULL
A.	NULL
D.	NULL
Canaris	NULL
,	NULL
A.	NULL
Cantalamessa	NULL
,	NULL
S.	NULL
Fiorentini	NULL
,	NULL
S.	NULL
Ausenda	NULL
,	NULL
D.	NULL
Ricotta	NULL
,	NULL
F.	NULL
Dima	NULL
,	NULL
and	NULL
F.	NULL
Malacarne	NULL
.	NULL

1998	NULL
.	NULL

Contribution	NULL
of	NULL
CD4	NULL
,	NULL
CD8	NULL
``	NULL
CD28	NULL
*	NULL
,	NULL
and	NULL
CD8*CD28~	NULL
T	NULL
cells	NULL
to	NULL
CD3*	NULL
lymphocyte	NULL
homeostasis	NULL
during	NULL
the	NULL
natural	NULL
course	NULL
of	NULL
HIV-1	NULL
infection	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

101:137	NULL
.	NULL

Posneft	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
R.	NULL
Sinha	NULL
,	NULL
S.	NULL
Kabak	NULL
,	NULL
and	NULL
C.	NULL
Russo	NULL
.	NULL

1994	NULL
.	NULL

Clonal	NULL
populations	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
normal	NULL
elderly	NULL
humans	NULL
:	NULL
The	NULL
T	NULL
cell	NULL
equivalent	NULL
to	NULL
``	NULL
benign	NULL
monoclonal	NULL
gammopathy	NULL
.	NULL
``	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:609	NULL
.	NULL

Batliwalla	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Montiero	NULL
,	NULL
D.	NULL
Serrano	NULL
,	NULL
and	NULL
P.	NULL
K.	NULL
Gregersen	NULL
.	NULL

1996	NULL
.	NULL

Oligoclonality	NULL
of	NULL
CD8*	NULL
T	NULL
cells	NULL
in	NULL
health	NULL
and	NULL
disease	NULL
:	NULL
aging	NULL
,	NULL
infection	NULL
,	NULL
or	NULL
immune	NULL
regulation	NULL
?	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

48:68	NULL
.	NULL

Dutra	NULL
,	NULL
W.	NULL
O.	NULL
,	NULL
O	NULL
.	NULL

A.	NULL
Martins-Filho	NULL
,	NULL
J.	NULL
R.	NULL
Cancado	NULL
,	NULL
J.	NULL
C.	NULL
Pinto-Dias	NULL
,	NULL
Z.	NULL
Brener	NULL
,	NULL
G.	NULL
Gazzinelli	NULL
,	NULL
J.	NULL
F.	NULL
Carvalho	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Colley	NULL
.	NULL

1996	NULL
.	NULL

Chagasic	NULL
patients	NULL
lack	NULL
CD28	NULL
expression	NULL
on	NULL
many	NULL
of	NULL
their	NULL
circulating	NULL
T	NULL
lymphocytes	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

43:88	NULL
.	NULL

Kem	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Ode-Hakim	NULL
,	NULL
K.	NULL
Vogt	NULL
,	NULL
C.	NULL
Hoflich	NULL
,	NULL
P.	NULL
Reinke	NULL
,	NULL
and	NULL
H.	NULL
D.	NULL
Volk	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
enigma	NULL
of	NULL
CD57	NULL
``	NULL
CD28	NULL
T	NULL
cell	NULL
expansion	NULL
:	NULL
anergy	NULL
or	NULL
activation	NULL
?	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

104:180	NULL
.	NULL

Garcia-Alonso	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
A.	NULL
Minguela	NULL
,	NULL
M.	NULL
Muro	NULL
,	NULL
J.	NULL
Ontanon	NULL
,	NULL
A.	NULL
Torio	NULL
,	NULL
L.	NULL
Marin	NULL
,	NULL
P.	NULL
Lopez-Segura	NULL
,	NULL
M.	NULL
Miras	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Alvarez-Lopez	NULL
.	NULL

1997	NULL
.	NULL

CD28	NULL
expression	NULL
on	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
after	NULL
orthotopic	NULL
liver	NULL
transplant	NULL
:	NULL
upregulation	NULL
in	NULL
acute	NULL
rejection	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

53:64	NULL
.	NULL

Turka	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
K.	NULL
Lee	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1990	NULL
.	NULL

CD28	NULL
is	NULL
an	NULL
inducible	NULL
T	NULL
cell	NULL
surface	NULL
antigen	NULL
that	NULL
transduces	NULL
a	NULL
proliferative	NULL
signal	NULL
in	NULL
CD3+	NULL
mature	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:1646	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

6579	NULL
Vingerhocts	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
G.	NULL
L.	NULL
Vanham	NULL
,	NULL
L.	NULL
L.	NULL
Kestens	NULL
,	NULL
G.	NULL
G.	NULL
Penne	NULL
,	NULL
R.	NULL
L.	NULL
Colebunders	NULL
,	NULL
M.	NULL
J.	NULL
Vandenbruaence	NULL
,	NULL
J.	NULL
Goeman	NULL
,	NULL
P.	NULL
L.	NULL
Gigase	NULL
,	NULL
M.	NULL
DeBoer	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Ceuppens	NULL
.	NULL

1995	NULL
.	NULL

Increased	NULL
cytolytic	NULL
T	NULL
lymphocyte	NULL
activity	NULL
and	NULL
decreased	NULL
B7	NULL
responsiveness	NULL
are	NULL
associated	NULL
with	NULL
CD28	NULL
down-regulation	NULL
on	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
HIV-infected	NULL
subjects	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

100:425.	NULL
.	NULL

Lloyd	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
L.	NULL
Yang	NULL
,	NULL
D.	NULL
N.	NULL
Tang	NULL
,	NULL
T.	NULL
Bennett	NULL
,	NULL
W.	NULL
Schober	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Lewis	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
CD28	NULL
co-stimulation	NULL
in	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:1551	NULL
.	NULL

Walker	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
J.	NULL
D.	NULL
McLeod	NULL
,	NULL
G.	NULL
Boulougouris	NULL
,	NULL
Y.	NULL
I.	NULL
Patel	NULL
,	NULL
N.	NULL
D.	NULL
Hall	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Sansom	NULL
.	NULL

1998	NULL
.	NULL

Down-regulation	NULL
of	NULL
CD28	NULL
via	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
:	NULL
influence	NULL
of	NULL
CD28	NULL
on	NULL
T	NULL
cell	NULL
apoptosis	NULL
.	NULL

Immunology	NULL
94:41	NULL
.	NULL

Pellat-Deceunynck	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
Bataille	NULL
,	NULL
N.	NULL
Robillard	NULL
,	NULL
J.	NULL
L.	NULL
Harousseau	NULL
,	NULL
M.	NULL
J.	NULL
Rapp	NULL
,	NULL
N.	NULL
Juge-Morineau	NULL
,	NULL
J.	NULL
Wijdenes	NULL
,	NULL
and	NULL
M.	NULL
Amiot	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
CD28	NULL
and	NULL
CD40	NULL
in	NULL
human	NULL
myeloma	NULL
cells	NULL
:	NULL
a	NULL
comparative	NULL
study	NULL
with	NULL
normal	NULL
plasma	NULL
cells	NULL
.	NULL

Blood	NULL
84:2597	NULL
.	NULL

Robillard	NULL
,	NULL
N.	NULL
,	NULL
G.	NULL
Jego	NULL
,	NULL
C.	NULL
Pellat-Deceunynck	NULL
,	NULL
D.	NULL
Pineau	NULL
,	NULL
D.	NULL
Puthier	NULL
,	NULL
M.	NULL
P.	NULL
Mellerin	NULL
,	NULL
S.	NULL
Barille	NULL
,	NULL
M.	NULL
J.	NULL
Rapp	NULL
,	NULL
J.	NULL
L.	NULL
Harousseau	NULL
,	NULL
M.	NULL
Amiot	NULL
,	NULL
and	NULL
R.	NULL
Bataille	NULL
.	NULL

1998	NULL
.	NULL

CD28	NULL
,	NULL
a	NULL
marker	NULL
associated	NULL
with	NULL
tumor	NULL
expansion	NULL
in	NULL
multiple	NULL
myeloma	NULL
.	NULL

Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

4:1521	NULL
.	NULL

Epstein	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Hoover	NULL
,	NULL
J.	NULL
Kombluth	NULL
,	NULL
and	NULL
B.	NULL
Barlogic	NULL
.	NULL

1995	NULL
.	NULL

Biological	NULL
aspects	NULL
of	NULL
multiple	NULL
myeloma	NULL
.	NULL

Baillieres	NULL
Clin	NULL
.	NULL

Haematol	NULL
.	NULL

8:721	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
G.	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
J.	NULL
Devos	NULL
,	NULL
C.	NULL
Rebouissou	NULL
,	NULL
M.	NULL
Ghiotto-Raguencau	NULL
,	NULL
M.	NULL
Ferlin	NULL
,	NULL
and	NULL
B.	NULL
Klein	NULL
.	NULL

1998	NULL
.	NULL

Malignant	NULL
plasma	NULL
cell	NULL
lines	NULL
express	NULL
a	NULL
functional	NULL
CD28	NULL
molecule	NULL
.	NULL

Leukemia	NULL
12:610	NULL
.	NULL

Weyand	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
J.	NULL
J.	NULL
Goronzy	NULL
,	NULL
and	NULL
G.	NULL
Fathman	NULL
.	NULL

1987	NULL
.	NULL

Modulation	NULL
of	NULL
CD4	NULL
by	NULL
antigenic	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

138:1351	NULL
.	NULL

Pelchen-Matthews	NULL
,	NULL
A.	NULL
,	NULL
I.	NULL
J.	NULL
Parsons	NULL
,	NULL
and	NULL
M.	NULL
Marsh	NULL
.	NULL

1993	NULL
.	NULL

Phorbol	NULL
ester-induced	NULL
down-regulation	NULL
of	NULL
CD4	NULL
is	NULL
a	NULL
multistep	NULL
process	NULL
involving	NULL
dissociation	NULL
from	NULL
p36	NULL
``	NULL
**	NULL
,	NULL
increased	NULL
association	NULL
with	NULL
clathrin-coated	NULL
pits	NULL
,	NULL
and	NULL
altered	NULL
endosomal	NULL
sorting	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1209	NULL
.	NULL

Cai	NULL
,	NULL
Z.	NULL
,	NULL
H.	NULL
Kishimoto	NULL
,	NULL
A.	NULL
Brunmark	NULL
,	NULL
M.	NULL
R.	NULL
Jackson	NULL
,	NULL
P.	NULL
A.	NULL
Peterson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Sprent	NULL
.	NULL

1997	NULL
.	NULL

Requirements	NULL
for	NULL
peptide-induced	NULL
T	NULL
cell	NULL
receptor	NULL
down-regulation	NULL
on	NULL
naive	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:641	NULL
.	NULL

Viola	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Sailo	NULL
,	NULL
L.	NULL
Tuosto	NULL
,	NULL
S.	NULL
Linkert	NULL
,	NULL
O.	NULL
Acuto	NULL
,	NULL
and	NULL
A.	NULL
Lanzavecchia	NULL
.	NULL

1997	NULL
.	NULL

Quantitative	NULL
contribution	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
to	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
serial	NULL
trig-gering	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:1775	NULL
.	NULL

Lauritsen	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
M.	NULL
D.	NULL
Christen	NULL
,	NULL
J.	NULL
Dietrich	NULL
,	NULL
J.	NULL
Kastrup	NULL
,	NULL
N.	NULL
Odum	NULL
,	NULL
and	NULL
C.	NULL
Geisler	NULL
.	NULL

1998	NULL
.	NULL

Two	NULL
distinct	NULL
pathways	NULL
exist	NULL
for	NULL
down-regulation	NULL
of	NULL
the	NULL
TCR	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:260	NULL
.	NULL

Pawelec	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Rehbein	NULL
,	NULL
K.	NULL
Hachnel	NULL
,	NULL
A.	NULL
Merl	NULL
,	NULL
and	NULL
M.	NULL
Adibzadeh	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
T	NULL
cell	NULL
clones	NULL
in	NULL
long	NULL
term	NULL
culture	NULL
as	NULL
a	NULL
model	NULL
of	NULL
immunosenescence	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

160:31	NULL
.	NULL

Monteiro	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Batliwalla	NULL
,	NULL
H.	NULL
Ostrer	NULL
,	NULL
and	NULL
P.	NULL
K.	NULL
Gregersen	NULL
.	NULL

1996	NULL
.	NULL

Shortened	NULL
telomeres	NULL
in	NULL
clonally	NULL
expanded	NULL
CD28	NULL
~CD8*	NULL
T	NULL
cells	NULL
imply	NULL
a	NULL
replicative	NULL
history	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
their	NULL
CD28	NULL
``	NULL
CD8	NULL
``	NULL
counterparts	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3587	NULL
.	NULL

Schmidt	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
B.	NULL
Martens	NULL
,	NULL
C.	NULL
M.	NULL
Weyand	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Goronzy	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
repertoire	NULL
of	NULL
CD4*	NULL
CD28	NULL
T	NULL
cells	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Mol	NULL
.	NULL

Med	NULL
.	NULL

2:608	NULL
.	NULL

Waase	NULL
,	NULL
I.	NULL
,	NULL
C.	NULL
Kayser	NULL
,	NULL
P.	NULL
J.	NULL
Carlson	NULL
,	NULL
J.	NULL
J.	NULL
Goronzy	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Weyand	NULL
.	NULL

1996	NULL
.	NULL

Oligoclonal	NULL
T	NULL
cell	NULL
proliferation	NULL
in	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
and	NULL
their	NULL
unaffected	NULL
siblings	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

39:904	NULL
.	NULL

Martens	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
J.	NULL
J.	NULL
Goronzy	NULL
,	NULL
D.	NULL
Schaid	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Weyand	NULL
.	NULL

1997	NULL
.	NULL

Expansion	NULL
of	NULL
unusual	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
severe	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
.	NULL

40:1106	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

